Search Name:	V20130429-06 BS p197-3 as1/results1
			V20130429-06 BS p197-3 as1/results1																					
	Uniq Pep	Acc #	UniProt ID	Gene	Num Unique	% Cov	Best Disc Score	Best Expect Val	m/z	z	ppm	DB Peptide	Peptide	Protein Mods	Length	Fraction	RT	Start	End	Score	Expect	P Value	# in DB	Protein MW	Species	Protein Name
[1]		P04406	G3P_HUMAN	GAPDH	19	60.9	10.49	7.9e-19	1147.0215	2	1.2	WGDAGAEYVVESTGVFTTMEK	WGDAGAEYVVESTGVFTTM(Oxidation)EK	Oxidation@105	21	V20130429-06_FTMSms2hcd	53.588	87	107	54.3	7.9e-19	8.0e-22	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	19	60.9	10.49	7.9e-19	779.0444	6	-4.9	AAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVK	AAFNSGKVDIVAINDPFIDLNYM(Oxidation)VYMFQYDSTHGKFHGTVK	Oxidation@43=39	41	V20130429-06_FTMSms2hcd	67.161	21	61	42.3	2.9e-16	4.4e-19	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	19	60.9	10.49	7.9e-19	1339.3059	3	3.7	AAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGK	AAFNSGKVDIVAINDPFIDLNYM(Oxidation)VYM(Oxidation)FQYDSTHGK	Oxidation@43;Oxidation@46	35	V20130429-06_FTMSms2hcd	69.381	21	55	43.1	3.7e-16	4.2e-19	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	19	60.9	10.49	7.9e-19	653.5953	4	1.7	VIHDNFGIVEGLMTTVHAITATQK	VIHDNFGIVEGLM(Oxidation)TTVHAITATQK	Oxidation@175	24	V20130429-06_FTMSms2hcd	61.745	163	186	53.4	4.2e-16	7.5e-19	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	19	60.9	10.49	7.9e-19	756.0629	3	2.6	LTGMAFRVPTANVSVVDLTCR	LTGM(Oxidation)AFRVPTANVSVVDLTCR	Oxidation@231	21	V20130429-06_FTMSms2hcd	52.610	228	248	46.4	2.2e-15	3.5e-18	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	19	60.9	10.49	7.9e-19	781.7155	6	1.9	AAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVK	AAFNSGKVDIVAINDPFIDLNYM(Oxidation)VYM(Oxidation)FQYDSTHGKFHGTVK	Oxidation@43;Oxidation@46	41	V20130429-06_FTMSms2hcd	65.106	21	61	46.8	1.1e-14	1.9e-17	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	19	60.9	10.49	7.9e-19	845.4106	3	2.1	IKWGDAGAEYVVESTGVFTTMEK	IKWGDAGAEYVVESTGVFTTM(Oxidation)EK	Oxidation@105	23	V20130429-06_FTMSms2hcd	53.842	85	107	46.7	1.1e-14	1.1e-17	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	19	60.9	10.49	7.9e-19	865.7935	3	2.3	VIHDNFGIVEGLMTTVHAITATQK	VIHDNFGIVEGLMTTVHAITATQK		24	V20130429-06_FTMSms2hcd	70.974	163	186	55.0	3.1e-14	7.2e-17	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	19	60.9	10.49	7.9e-19	1108.8552	3	-2.4	VDIVAINDPFIDLNYMVYMFQYDSTHGK	VDIVAINDPFIDLNYM(Oxidation)VYMFQYDSTHGK	Oxidation@43=48	28	V20130429-06_FTMSms2hcd	74.623	28	55	30.5	4.3e-14	4.1e-17	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	19	60.9	10.49	7.9e-19	1000.7305	4	1.7	AAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGK	AAFNSGKVDIVAINDPFIDLNYM(Oxidation)VYMFQYDSTHGK	Oxidation@43=31	35	V20130429-06_FTMSms2hcd	71.477	21	55	45.5	1.5e-13	1.8e-16	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	19	60.9	10.49	7.9e-19	882.4050	2	0.20	LISWYDNEFGYSNR	LISWYDNEFGYSNR		14	V20130429-06_FTMSms2hcd	49.556	310	323	53.9	1.7e-13	1.9e-16	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	19	60.9	10.49	7.9e-19	779.0487	6	0.60	AAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVK	AAFNSGKVDIVAINDPFIDLNYMVYM(Oxidation)FQYDSTHGKFHGTVK	Oxidation@46=38	41	V20130429-06_FTMSms2hcd	75.153	21	61	42.4	3.0e-13	4.8e-16	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	19	60.9	10.49	7.9e-19	970.2749	5	5.6	QASEGPLKGILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK	QASEGPLKGILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK		46	V20130429-06_FTMSms2hcd	58.778	264	309	39.5	9.1e-10	1.6e-12	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	19	60.9	10.49	7.9e-19	737.3898	2	-0.45	VPTANVSVVDLTCR	VPTANVSVVDLTCR		14	V20130429-06_FTMSms2hcd	43.226	235	248	53.0	1.5e-9	2.5e-12	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	19	60.9	10.49	7.9e-19	966.8597	5	-4.6	QASEGPLKGILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK	Q(Gln->pyro-Glu)ASEGPLKGILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK	Gln->pyro-Glu@264	46	V20130429-06_FTMSms2hcd	62.779	264	309	33.1	5.6e-9	8.9e-12	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	19	60.9	10.49	7.9e-19	706.4000	2	1.7	GALQNIIPASTGAAK	GALQNIIPASTGAAK		15	V20130429-06_FTMSms2hcd	38.920	201	215	28.4	8.2e-8	2.2e-10	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	19	60.9	10.49	7.9e-19	362.7097	4	1.0	LEKPAKYDDIKK	LEKPAKYDDIKK		12	V20130429-06_FTMSms2hcd	14.097	249	260	29.2	3.5e-7	1.1e-9	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	19	60.9	10.49	7.9e-19	403.2197	2	0.76	VGVNGFGR	VGVNGFGR		8	V20130429-06_FTMSms2hcd	22.151	6	13	28.2	1.4e-6	2.6e-9	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[1]		P04406	G3P_HUMAN	GAPDH	19	60.9	10.49	7.9e-19	835.8900	4	-4.8	VDIVAINDPFIDLNYMVYMFQYDSTHGK	VDIVAINDPFIDLNYM(Oxidation)VYM(Oxidation)FQYDSTHGK	Oxidation@43;Oxidation@46	28	V20130429-06_FTMSms2hcd	72.304	28	55	14.8	6.7e-6	6.6e-9	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P14618	KPYM_HUMAN	PKM2	11	29.2	9.86	1.2e-17	755.1545	4	0.64	TATESFASDPILYRPVAVALDTKGPEIR	TATESFASDPILYRPVAVALDTKGPEIR		28	V20130429-06_FTMSms2hcd	56.499	93	120	53.2	1.2e-17	3.0e-20	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[2]		P14618	KPYM_HUMAN	PKM2	11	29.2	9.86	1.2e-17	663.3369	3	0.77	FGVEQDVDMVFASFIRK	FGVEQDVDMVFASFIRK		17	V20130429-06_FTMSms2hcd	71.317	231	247	37.5	3.4e-15	4.0e-18	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[2]		P14618	KPYM_HUMAN	PKM2	11	29.2	9.86	1.2e-17	1088.0636	2	0.90	LAPITSDPTEATAVGAVEASFK	LAPITSDPTEATAVGAVEASFK		22	V20130429-06_FTMSms2hcd	55.356	401	422	49.4	1.5e-14	2.0e-17	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[2]		P14618	KPYM_HUMAN	PKM2	11	29.2	9.86	1.2e-17	668.6688	3	1.2	FGVEQDVDMVFASFIRK	FGVEQDVDM(Oxidation)VFASFIRK	Oxidation@239	17	V20130429-06_FTMSms2hcd	67.872	231	247	37.6	3.6e-14	3.9e-17	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[2]		P14618	KPYM_HUMAN	PKM2	11	29.2	9.86	1.2e-17	883.4135	4	2.0	MSKPHSEAGTAFIQTQQLHAAMADTFLEHMCR	M(Met-loss+Acetyl)SKPHSEAGTAFIQTQQLHAAM(Oxidation)ADTFLEHM(Oxidation)CR	Met-loss+Acetyl@1;Oxidation@22;Oxidation@30	32	V20130429-06_FTMSms2hcd	45.196	1	32	47.0	3.8e-12	3.9e-15	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[2]		P14618	KPYM_HUMAN	PKM2	11	29.2	9.86	1.2e-17	696.7014	3	1.1	EAEAAIYHLQLFEELRR	EAEAAIYHLQLFEELRR		17	V20130429-06_FTMSms2hcd	53.399	384	400	55.7	1.9e-11	3.0e-14	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[2]		P14618	KPYM_HUMAN	PKM2	11	29.2	9.86	1.2e-17	722.3911	4	12	GFFKKGDVVIVLTGWRPGSGFTNTMR	GFFKKGDVVIVLTGWRPGSGFTNTM(Oxidation)R	Oxidation@525	26	V20130429-06_FTMSms2hcd	54.902	501	526	34.6	6.2e-10	1.9e-12	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[2]		P14618	KPYM_HUMAN	PKM2	11	29.2	9.86	1.2e-17	651.8453	2	-0.094	NTGIICTIGPASR	NTGIICTIGPASR		13	V20130429-06_FTMSms2hcd	36.875	44	56	37.6	3.3e-9	4.8e-12	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[2]		P14618	KPYM_HUMAN	PKM2	11	29.2	9.86	1.2e-17	644.6666	3	-0.47	EAEAAIYHLQLFEELR	EAEAAIYHLQLFEELR		16	V20130429-06_FTMSms2hcd	58.377	384	399	28.4	1.3e-8	1.6e-11	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[2]		P14618	KPYM_HUMAN	PKM2	11	29.2	9.86	1.2e-17	602.5692	4	-0.043	KGDVVIVLTGWRPGSGFTNTMR	KGDVVIVLTGWRPGSGFTNTM(Oxidation)R	Oxidation@525	22	V20130429-06_FTMSms2hcd	50.172	505	526	25.6	1.3e-8	2.4e-11	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[2]		P14618	KPYM_HUMAN	PKM2	11	29.2	9.86	1.2e-17	625.9701	3	0.63	FGVEQDVDMVFASFIR	FGVEQDVDM(Oxidation)VFASFIR	Oxidation@239	16	V20130429-06_FTMSms2hcd	73.713	231	246	26.8	2.4e-8	2.6e-11	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[3]		P68104	EF1A1_HUMAN	EEF1A1	10	33.3	9.96	7.6e-18	956.8215	3	13	NMITGTSQADCAVLIVAAGVGEFEAGISK	NM(Oxidation)ITGTSQADCAVLIVAAGVGEFEAGISK	Oxidation@102	29	V20130429-06_FTMSms2hcd	77.209	101	129	60.5	7.6e-18	1.1e-20	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[3]		P68104	EF1A1_HUMAN	EEF1A1	10	33.3	9.96	7.6e-18	794.9479	2	5.0	THINIVVIGHVDSGK	THINIVVIGHVDSGK		15	V20130429-06_FTMSms2hcd	78.100	6	20	41.8	2.4e-17	6.1e-20	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[3]		P68104	EF1A1_HUMAN	EEF1A1	10	33.3	9.96	7.6e-18	897.4940	3	1.9	THINIVVIGHVDSGKSTTTGHLIYK	THINIVVIGHVDSGKSTTTGHLIYK		25	V20130429-06_FTMSms2hcd	37.732	6	30	51.0	7.5e-16	3.1e-18	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[3]		P68104	EF1A1_HUMAN	EEF1A1	10	33.3	9.96	7.6e-18	981.0280	4	2.8	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		36	V20130429-06_FTMSms2hcd	74.196	220	255	42.7	1.4e-13	6.2e-16	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[3]		P68104	EF1A1_HUMAN	EEF1A1	10	33.3	9.96	7.6e-18	542.9398	3	0.31	TIEKFEKEAAEMGK	TIEKFEKEAAEM(Oxidation)GK	Oxidation@49	14	V20130429-06_FTMSms2hcd	21.478	38	51	40.5	1.9e-11	2.3e-14	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[3]		P68104	EF1A1_HUMAN	EEF1A1	10	33.3	9.96	7.6e-18	1142.2389	3	5.4	NMITGTSQADCAVLIVAAGVGEFEAGISKNGQTR	NM(Oxidation)ITGTSQADCAVLIVAAGVGEFEAGISKNGQTR	Oxidation@102	34	V20130429-06_FTMSms2hcd	74.936	101	134	35.1	1.5e-10	1.9e-13	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[3]		P68104	EF1A1_HUMAN	EEF1A1	10	33.3	9.96	7.6e-18	1013.0501	4	1.1	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		37	V20130429-06_FTMSms2hcd	70.210	219	255	35.0	5.4e-10	3.0e-12	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[3]		P68104	EF1A1_HUMAN	EEF1A1	10	33.3	9.96	7.6e-18	844.4659	3	1.7	VETGVLKPGMVVTFAPVNVTTEVK	VETGVLKPGM(Oxidation)VVTFAPVNVTTEVK	Oxidation@276	24	V20130429-06_FTMSms2hcd	51.356	267	290	37.8	1.8e-9	7.0e-12	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[3]		P68104	EF1A1_HUMAN	EEF1A1	10	33.3	9.96	7.6e-18	513.3096	2	1.7	IGGIGTVPVGR	IGGIGTVPVGR		11	V20130429-06_FTMSms2hcd	31.205	256	266	38.9	2.1e-6	1.5e-8	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[3]		P68104	EF1A1_HUMAN	EEF1A1	10	33.3	9.96	7.6e-18	457.7863	2	-1.8	QTVAVGVIK	QTVAVGVIK		9	V20130429-06_FTMSms2hcd	26.410	431	439	27.9	6.8e-6	2.0e-8	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[3-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	10	33.3	9.96	7.6e-18	956.8215	3	13	NMITGTSQADCAVLIVAAGVGEFEAGISK	NM(Oxidation)ITGTSQADCAVLIVAAGVGEFEAGISK	Oxidation@102	29	V20130429-06_FTMSms2hcd	77.209	101	129	60.5	7.6e-18	1.1e-20	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[3-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	10	33.3	9.96	7.6e-18	794.9479	2	5.0	THINIVVIGHVDSGK	THINIVVIGHVDSGK		15	V20130429-06_FTMSms2hcd	78.100	6	20	41.8	2.4e-17	6.1e-20	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[3-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	10	33.3	9.96	7.6e-18	897.4940	3	1.9	THINIVVIGHVDSGKSTTTGHLIYK	THINIVVIGHVDSGKSTTTGHLIYK		25	V20130429-06_FTMSms2hcd	37.732	6	30	51.0	7.5e-16	3.1e-18	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[3-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	10	33.3	9.96	7.6e-18	981.0280	4	2.8	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		36	V20130429-06_FTMSms2hcd	74.196	220	255	42.7	1.4e-13	6.2e-16	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[3-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	10	33.3	9.96	7.6e-18	542.9398	3	0.31	TIEKFEKEAAEMGK	TIEKFEKEAAEM(Oxidation)GK	Oxidation@49	14	V20130429-06_FTMSms2hcd	21.478	38	51	40.5	1.9e-11	2.3e-14	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[3-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	10	33.3	9.96	7.6e-18	1142.2389	3	5.4	NMITGTSQADCAVLIVAAGVGEFEAGISKNGQTR	NM(Oxidation)ITGTSQADCAVLIVAAGVGEFEAGISKNGQTR	Oxidation@102	34	V20130429-06_FTMSms2hcd	74.936	101	134	35.1	1.5e-10	1.9e-13	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[3-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	10	33.3	9.96	7.6e-18	1013.0501	4	1.1	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		37	V20130429-06_FTMSms2hcd	70.210	219	255	35.0	5.4e-10	3.0e-12	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[3-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	10	33.3	9.96	7.6e-18	844.4659	3	1.7	VETGVLKPGMVVTFAPVNVTTEVK	VETGVLKPGM(Oxidation)VVTFAPVNVTTEVK	Oxidation@276	24	V20130429-06_FTMSms2hcd	51.356	267	290	37.8	1.8e-9	7.0e-12	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[3-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	10	33.3	9.96	7.6e-18	513.3096	2	1.7	IGGIGTVPVGR	IGGIGTVPVGR		11	V20130429-06_FTMSms2hcd	31.205	256	266	38.9	2.1e-6	1.5e-8	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[3-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	10	33.3	9.96	7.6e-18	457.7863	2	-1.8	QTVAVGVIK	QTVAVGVIK		9	V20130429-06_FTMSms2hcd	26.410	431	439	27.9	6.8e-6	2.0e-8	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[3-2]	0	Q05639	EF1A2_HUMAN	EEF1A2	7	20.1	9.96	7.6e-18	956.8215	3	13	NMITGTSQADCAVLIVAAGVGEFEAGISK	NM(Oxidation)ITGTSQADCAVLIVAAGVGEFEAGISK	Oxidation@102	29	V20130429-06_FTMSms2hcd	77.209	101	129	60.5	7.6e-18	1.1e-20	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[3-2]	0	Q05639	EF1A2_HUMAN	EEF1A2	7	20.1	9.96	7.6e-18	794.9479	2	5.0	THINIVVIGHVDSGK	THINIVVIGHVDSGK		15	V20130429-06_FTMSms2hcd	78.100	6	20	41.8	2.4e-17	6.1e-20	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[3-2]	0	Q05639	EF1A2_HUMAN	EEF1A2	7	20.1	9.96	7.6e-18	897.4940	3	1.9	THINIVVIGHVDSGKSTTTGHLIYK	THINIVVIGHVDSGKSTTTGHLIYK		25	V20130429-06_FTMSms2hcd	37.732	6	30	51.0	7.5e-16	3.1e-18	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[3-2]	0	Q05639	EF1A2_HUMAN	EEF1A2	7	20.1	9.96	7.6e-18	542.9398	3	0.31	TIEKFEKEAAEMGK	TIEKFEKEAAEM(Oxidation)GK	Oxidation@49	14	V20130429-06_FTMSms2hcd	21.478	38	51	40.5	1.9e-11	2.3e-14	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[3-2]	0	Q05639	EF1A2_HUMAN	EEF1A2	7	20.1	9.96	7.6e-18	1142.2389	3	5.4	NMITGTSQADCAVLIVAAGVGEFEAGISKNGQTR	NM(Oxidation)ITGTSQADCAVLIVAAGVGEFEAGISKNGQTR	Oxidation@102	34	V20130429-06_FTMSms2hcd	74.936	101	134	35.1	1.5e-10	1.9e-13	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[3-2]	0	Q05639	EF1A2_HUMAN	EEF1A2	7	20.1	9.96	7.6e-18	513.3096	2	1.7	IGGIGTVPVGR	IGGIGTVPVGR		11	V20130429-06_FTMSms2hcd	31.205	256	266	38.9	2.1e-6	1.5e-8	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[3-2]	0	Q05639	EF1A2_HUMAN	EEF1A2	7	20.1	9.96	7.6e-18	457.7863	2	-1.8	QTVAVGVIK	QTVAVGVIK		9	V20130429-06_FTMSms2hcd	26.410	431	439	27.9	6.8e-6	2.0e-8	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[4]		P60709	ACTB_HUMAN	ACTB	10	42.1	12.71	6.4e-23	890.8922	2	2.4	MDDDIAALVVDNGSGMCK	M(Met-loss+Acetyl)DDDIAALVVDNGSGM(Oxidation)CK	Met-loss+Acetyl@1;Oxidation@16	18	V20130429-06_FTMSms2hcd	52.248	1	18	53.2	6.4e-23	8.3e-26	1	41737.1	HUMAN	Actin, cytoplasmic 1
[4]		P60709	ACTB_HUMAN	ACTB	10	42.1	12.71	6.4e-23	849.6355	5	8.6	YSVWIGGSILASLSTFQQMWISKQEYDESGPSIVHRK	YSVWIGGSILASLSTFQQM(Oxidation)WISKQEYDESGPSIVHRK	Oxidation@355	37	V20130429-06_FTMSms2hcd	76.895	337	373	44.2	8.5e-16	1.7e-18	2	41737.1	HUMAN	Actin, cytoplasmic 1
[4]		P60709	ACTB_HUMAN	ACTB	10	42.1	12.71	6.4e-23	895.9587	2	10	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-06_FTMSms2hcd	47.776	239	254	48.3	2.2e-14	2.8e-17	10	41737.1	HUMAN	Actin, cytoplasmic 1
[4]		P60709	ACTB_HUMAN	ACTB	10	42.1	12.71	6.4e-23	589.3108	2	0.87	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@325	11	V20130429-06_FTMSms2hcd	24.988	316	326	37.6	2.9e-12	4.4e-15	6	41737.1	HUMAN	Actin, cytoplasmic 1
[4]		P60709	ACTB_HUMAN	ACTB	10	42.1	12.71	6.4e-23	977.5354	2	-0.45	VAPEEHPVLLTEAPLNPK	VAPEEHPVLLTEAPLNPK		18	V20130429-06_FTMSms2hcd	40.977	96	113	41.5	4.7e-11	1.2e-13	2	41737.1	HUMAN	Actin, cytoplasmic 1
[4]		P60709	ACTB_HUMAN	ACTB	10	42.1	12.71	6.4e-23	677.8161	2	1.2	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-06_FTMSms2hcd	11.773	51	62	42.1	3.1e-10	4.0e-13	6	41737.1	HUMAN	Actin, cytoplasmic 1
[4]		P60709	ACTB_HUMAN	ACTB	10	42.1	12.71	6.4e-23	400.2402	3	0.45	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-06_FTMSms2hcd	35.303	29	39	39.5	1.0e-9	3.7e-12	9	41737.1	HUMAN	Actin, cytoplasmic 1
[4]		P60709	ACTB_HUMAN	ACTB	10	42.1	12.71	6.4e-23	831.7231	3	0.95	LCYVALDFEQEMATAASSSSLEK	LCYVALDFEQEMATAASSSSLEK		23	V20130429-06_FTMSms2hcd	66.149	216	238	22.8	4.7e-8	4.5e-11	3	41737.1	HUMAN	Actin, cytoplasmic 1
[4]		P60709	ACTB_HUMAN	ACTB	10	42.1	12.71	6.4e-23	360.6717	2	2.3	CDVDIR	CDVDIR		6	V20130429-06_FTMSms2hcd	16.218	285	290	24.2	0.0041	1.3e-5	3	41737.1	HUMAN	Actin, cytoplasmic 1
[4]		P60709	ACTB_HUMAN	ACTB	10	42.1	12.71	6.4e-23	400.7715	2	0.59	RGILTLK	RGILTLK		7	V20130429-06_FTMSms2hcd	25.415	62	68	13.6	0.090	5.5e-4	10	41737.1	HUMAN	Actin, cytoplasmic 1
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	10	42.1	11.84	2.5e-21	918.9227	2	1.5	MEEEIAALVIDNGSGMCK	M(Met-loss+Acetyl)EEEIAALVIDNGSGM(Oxidation)CK	Met-loss+Acetyl@1;Oxidation@16	18	V20130429-06_FTMSms2hcd	60.580	1	18	57.0	2.5e-21	2.7e-24	1	41793.2	HUMAN	Actin, cytoplasmic 2
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	10	42.1	11.84	2.5e-21	849.6355	5	8.6	YSVWIGGSILASLSTFQQMWISKQEYDESGPSIVHRK	YSVWIGGSILASLSTFQQM(Oxidation)WISKQEYDESGPSIVHRK	Oxidation@355	37	V20130429-06_FTMSms2hcd	76.895	337	373	44.2	8.5e-16	1.7e-18	2	41793.2	HUMAN	Actin, cytoplasmic 2
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	10	42.1	11.84	2.5e-21	895.9587	2	10	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-06_FTMSms2hcd	47.776	239	254	48.3	2.2e-14	2.8e-17	10	41793.2	HUMAN	Actin, cytoplasmic 2
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	10	42.1	11.84	2.5e-21	589.3108	2	0.87	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@325	11	V20130429-06_FTMSms2hcd	24.988	316	326	37.6	2.9e-12	4.4e-15	6	41793.2	HUMAN	Actin, cytoplasmic 2
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	10	42.1	11.84	2.5e-21	977.5354	2	-0.45	VAPEEHPVLLTEAPLNPK	VAPEEHPVLLTEAPLNPK		18	V20130429-06_FTMSms2hcd	40.977	96	113	41.5	4.7e-11	1.2e-13	2	41793.2	HUMAN	Actin, cytoplasmic 2
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	10	42.1	11.84	2.5e-21	677.8161	2	1.2	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-06_FTMSms2hcd	11.773	51	62	42.1	3.1e-10	4.0e-13	6	41793.2	HUMAN	Actin, cytoplasmic 2
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	10	42.1	11.84	2.5e-21	400.2402	3	0.45	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-06_FTMSms2hcd	35.303	29	39	39.5	1.0e-9	3.7e-12	9	41793.2	HUMAN	Actin, cytoplasmic 2
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	10	42.1	11.84	2.5e-21	831.7231	3	0.95	LCYVALDFEQEMATAASSSSLEK	LCYVALDFEQEMATAASSSSLEK		23	V20130429-06_FTMSms2hcd	66.149	216	238	22.8	4.7e-8	4.5e-11	3	41793.2	HUMAN	Actin, cytoplasmic 2
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	10	42.1	11.84	2.5e-21	360.6717	2	2.3	CDVDIR	CDVDIR		6	V20130429-06_FTMSms2hcd	16.218	285	290	24.2	0.0041	1.3e-5	3	41793.2	HUMAN	Actin, cytoplasmic 2
[4-1]	1	P63261	ACTG_HUMAN	ACTG1	10	42.1	11.84	2.5e-21	400.7715	2	0.59	RGILTLK	RGILTLK		7	V20130429-06_FTMSms2hcd	25.415	62	68	13.6	0.090	5.5e-4	10	41793.2	HUMAN	Actin, cytoplasmic 2
[4-2]	2	P68032	ACTC_HUMAN	ACTC1	7	29.4	8.09	2.2e-14	895.9587	2	10	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-06_FTMSms2hcd	47.776	241	256	48.3	2.2e-14	2.8e-17	10	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[4-2]	2	P68032	ACTC_HUMAN	ACTC1	7	29.4	8.09	2.2e-14	589.3108	2	0.87	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@327	11	V20130429-06_FTMSms2hcd	24.988	318	328	37.6	2.9e-12	4.4e-15	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[4-2]	2	P68032	ACTC_HUMAN	ACTC1	7	29.4	8.09	2.2e-14	677.8161	2	1.2	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-06_FTMSms2hcd	11.773	53	64	42.1	3.1e-10	4.0e-13	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[4-2]	2	P68032	ACTC_HUMAN	ACTC1	7	29.4	8.09	2.2e-14	869.1699	4	5.9	YPIEHGIITNWDDMEKIWHHTFYNELR	YPIEHGIITNWDDM(Oxidation)EKIWHHTFYNELR	Oxidation@84	27	V20130429-06_FTMSms2hcd	53.748	71	97	32.8	5.3e-10	5.6e-13	2	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[4-2]	2	P68032	ACTC_HUMAN	ACTC1	7	29.4	8.09	2.2e-14	400.2402	3	0.45	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-06_FTMSms2hcd	35.303	31	41	39.5	1.0e-9	3.7e-12	9	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[4-2]	2	P68032	ACTC_HUMAN	ACTC1	7	29.4	8.09	2.2e-14	1049.8040	3	-16	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@271=37	28	V20130429-06_FTMSms2hcd	59.176	259	286	15.3	2.2e-5	2.1e-8	4	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[4-2]	2	P68032	ACTC_HUMAN	ACTC1	7	29.4	8.09	2.2e-14	400.7715	2	0.59	RGILTLK	RGILTLK		7	V20130429-06_FTMSms2hcd	25.415	64	70	13.6	0.090	5.5e-4	10	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[4-3]	2	P68133	ACTS_HUMAN	ACTA1	7	29.4	8.09	2.2e-14	895.9587	2	10	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-06_FTMSms2hcd	47.776	241	256	48.3	2.2e-14	2.8e-17	10	42051.4	HUMAN	Actin, alpha skeletal muscle
[4-3]	2	P68133	ACTS_HUMAN	ACTA1	7	29.4	8.09	2.2e-14	589.3108	2	0.87	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@327	11	V20130429-06_FTMSms2hcd	24.988	318	328	37.6	2.9e-12	4.4e-15	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[4-3]	2	P68133	ACTS_HUMAN	ACTA1	7	29.4	8.09	2.2e-14	677.8161	2	1.2	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-06_FTMSms2hcd	11.773	53	64	42.1	3.1e-10	4.0e-13	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[4-3]	2	P68133	ACTS_HUMAN	ACTA1	7	29.4	8.09	2.2e-14	869.1699	4	5.9	YPIEHGIITNWDDMEKIWHHTFYNELR	YPIEHGIITNWDDM(Oxidation)EKIWHHTFYNELR	Oxidation@84	27	V20130429-06_FTMSms2hcd	53.748	71	97	32.8	5.3e-10	5.6e-13	2	42051.4	HUMAN	Actin, alpha skeletal muscle
[4-3]	2	P68133	ACTS_HUMAN	ACTA1	7	29.4	8.09	2.2e-14	400.2402	3	0.45	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-06_FTMSms2hcd	35.303	31	41	39.5	1.0e-9	3.7e-12	9	42051.4	HUMAN	Actin, alpha skeletal muscle
[4-3]	2	P68133	ACTS_HUMAN	ACTA1	7	29.4	8.09	2.2e-14	1049.8040	3	-16	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@271=37	28	V20130429-06_FTMSms2hcd	59.176	259	286	15.3	2.2e-5	2.1e-8	4	42051.4	HUMAN	Actin, alpha skeletal muscle
[4-3]	2	P68133	ACTS_HUMAN	ACTA1	7	29.4	8.09	2.2e-14	400.7715	2	0.59	RGILTLK	RGILTLK		7	V20130429-06_FTMSms2hcd	25.415	64	70	13.6	0.090	5.5e-4	10	42051.4	HUMAN	Actin, alpha skeletal muscle
[4-4]	1	P62736	ACTA_HUMAN	ACTA2	6	22.3	8.09	2.2e-14	895.9587	2	10	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-06_FTMSms2hcd	47.776	241	256	48.3	2.2e-14	2.8e-17	10	42009.4	HUMAN	Actin, aortic smooth muscle
[4-4]	1	P62736	ACTA_HUMAN	ACTA2	6	22.3	8.09	2.2e-14	589.3108	2	0.87	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@327	11	V20130429-06_FTMSms2hcd	24.988	318	328	37.6	2.9e-12	4.4e-15	6	42009.4	HUMAN	Actin, aortic smooth muscle
[4-4]	1	P62736	ACTA_HUMAN	ACTA2	6	22.3	8.09	2.2e-14	677.8161	2	1.2	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-06_FTMSms2hcd	11.773	53	64	42.1	3.1e-10	4.0e-13	6	42009.4	HUMAN	Actin, aortic smooth muscle
[4-4]	1	P62736	ACTA_HUMAN	ACTA2	6	22.3	8.09	2.2e-14	400.2402	3	0.45	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-06_FTMSms2hcd	35.303	31	41	39.5	1.0e-9	3.7e-12	9	42009.4	HUMAN	Actin, aortic smooth muscle
[4-4]	1	P62736	ACTA_HUMAN	ACTA2	6	22.3	8.09	2.2e-14	1049.8040	3	-16	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@271=37	28	V20130429-06_FTMSms2hcd	59.176	259	286	15.3	2.2e-5	2.1e-8	4	42009.4	HUMAN	Actin, aortic smooth muscle
[4-4]	1	P62736	ACTA_HUMAN	ACTA2	6	22.3	8.09	2.2e-14	400.7715	2	0.59	RGILTLK	RGILTLK		7	V20130429-06_FTMSms2hcd	25.415	64	70	13.6	0.090	5.5e-4	10	42009.4	HUMAN	Actin, aortic smooth muscle
[4-5]	1	P63267	ACTH_HUMAN	ACTG2	6	22.3	8.09	2.2e-14	895.9587	2	10	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-06_FTMSms2hcd	47.776	240	255	48.3	2.2e-14	2.8e-17	10	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[4-5]	1	P63267	ACTH_HUMAN	ACTG2	6	22.3	8.09	2.2e-14	589.3108	2	0.87	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@326	11	V20130429-06_FTMSms2hcd	24.988	317	327	37.6	2.9e-12	4.4e-15	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[4-5]	1	P63267	ACTH_HUMAN	ACTG2	6	22.3	8.09	2.2e-14	677.8161	2	1.2	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-06_FTMSms2hcd	11.773	52	63	42.1	3.1e-10	4.0e-13	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[4-5]	1	P63267	ACTH_HUMAN	ACTG2	6	22.3	8.09	2.2e-14	400.2402	3	0.45	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-06_FTMSms2hcd	35.303	30	40	39.5	1.0e-9	3.7e-12	9	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[4-5]	1	P63267	ACTH_HUMAN	ACTG2	6	22.3	8.09	2.2e-14	1049.8040	3	-16	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@270=37	28	V20130429-06_FTMSms2hcd	59.176	258	285	15.3	2.2e-5	2.1e-8	4	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[4-5]	1	P63267	ACTH_HUMAN	ACTG2	6	22.3	8.09	2.2e-14	400.7715	2	0.59	RGILTLK	RGILTLK		7	V20130429-06_FTMSms2hcd	25.415	63	69	13.6	0.090	5.5e-4	10	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[4-6]	0	Q6S8J3	POTEE_HUMAN	POTEE	4	5.3	8.09	2.2e-14	895.9587	2	10	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-06_FTMSms2hcd	47.776	939	954	48.3	2.2e-14	2.8e-17	10	121364.6	HUMAN	POTE ankyrin domain family member E
[4-6]	0	Q6S8J3	POTEE_HUMAN	POTEE	4	5.3	8.09	2.2e-14	400.2402	3	0.45	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-06_FTMSms2hcd	35.303	729	739	39.5	1.0e-9	3.7e-12	9	121364.6	HUMAN	POTE ankyrin domain family member E
[4-6]	0	Q6S8J3	POTEE_HUMAN	POTEE	4	5.3	8.09	2.2e-14	831.7231	3	0.95	LCYVALDFEQEMATAASSSSLEK	LCYVALDFEQEMATAASSSSLEK		23	V20130429-06_FTMSms2hcd	66.149	916	938	22.8	4.7e-8	4.5e-11	3	121364.6	HUMAN	POTE ankyrin domain family member E
[4-6]	0	Q6S8J3	POTEE_HUMAN	POTEE	4	5.3	8.09	2.2e-14	400.7715	2	0.59	RGILTLK	RGILTLK		7	V20130429-06_FTMSms2hcd	25.415	762	768	13.6	0.090	5.5e-4	10	121364.6	HUMAN	POTE ankyrin domain family member E
[4-7]	0	A5A3E0	POTEF_HUMAN	POTEF	3	3.2	8.09	2.2e-14	895.9587	2	10	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-06_FTMSms2hcd	47.776	939	954	48.3	2.2e-14	2.8e-17	10	121445.7	HUMAN	POTE ankyrin domain family member F
[4-7]	0	A5A3E0	POTEF_HUMAN	POTEF	3	3.2	8.09	2.2e-14	400.2402	3	0.45	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-06_FTMSms2hcd	35.303	729	739	39.5	1.0e-9	3.7e-12	9	121445.7	HUMAN	POTE ankyrin domain family member F
[4-7]	0	A5A3E0	POTEF_HUMAN	POTEF	3	3.2	8.09	2.2e-14	400.7715	2	0.59	RGILTLK	RGILTLK		7	V20130429-06_FTMSms2hcd	25.415	762	768	13.6	0.090	5.5e-4	10	121445.7	HUMAN	POTE ankyrin domain family member F
[4-8]	0	Q562R1	ACTBL_HUMAN	ACTBL2	2	5.9	8.09	2.2e-14	895.9587	2	10	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-06_FTMSms2hcd	47.776	240	255	48.3	2.2e-14	2.8e-17	10	42003.6	HUMAN	Beta-actin-like protein 2
[4-8]	0	Q562R1	ACTBL_HUMAN	ACTBL2	2	5.9	8.09	2.2e-14	360.6717	2	2.3	CDVDIR	CDVDIR		6	V20130429-06_FTMSms2hcd	16.218	286	291	24.2	0.0041	1.3e-5	3	42003.6	HUMAN	Beta-actin-like protein 2
[4-9]	0	Q9BYX7	ACTBM_HUMAN	POTEKP	1	4.3	8.09	2.2e-14	895.9587	2	10	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-06_FTMSms2hcd	47.776	239	254	48.3	2.2e-14	2.8e-17	10	42016.6	HUMAN	Putative beta-actin-like protein 3
[4-10]	0	P0CG38	POTEI_HUMAN	POTEI	2	1.7	5.53	1.0e-9	400.2402	3	0.45	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-06_FTMSms2hcd	35.303	729	739	39.5	1.0e-9	3.7e-12	9	121283.5	HUMAN	POTE ankyrin domain family member I
[4-10]	0	P0CG38	POTEI_HUMAN	POTEI	2	1.7	5.53	1.0e-9	400.7715	2	0.59	RGILTLK	RGILTLK		7	V20130429-06_FTMSms2hcd	25.415	762	768	13.6	0.090	5.5e-4	10	121283.5	HUMAN	POTE ankyrin domain family member I
[5]		P10809	CH60_HUMAN	HSPD1	7	21.1	9.57	4.1e-17	1073.0704	2	1.9	ALMLQGVDLLADAVAVTMGPK	ALM(Oxidation)LQGVDLLADAVAVTM(Oxidation)GPK	Oxidation@40;Oxidation@55	21	V20130429-06_FTMSms2hcd	70.422	38	58	50.3	4.1e-17	7.4e-20	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[5]		P10809	CH60_HUMAN	HSPD1	7	21.1	9.57	4.1e-17	710.3849	3	2.7	ALMLQGVDLLADAVAVTMGPK	ALMLQGVDLLADAVAVTM(Oxidation)GPK	Oxidation@55=128	21	V20130429-06_FTMSms2hcd	75.205	38	58	40.9	4.2e-14	9.0e-17	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[5]		P10809	CH60_HUMAN	HSPD1	7	21.1	9.57	4.1e-17	524.9726	3	0.19	GVMLAVDAVIAELKK	GVM(Oxidation)LAVDAVIAELKK	Oxidation@145	15	V20130429-06_FTMSms2hcd	59.284	143	157	36.4	3.3e-12	1.5e-14	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[5]		P10809	CH60_HUMAN	HSPD1	7	21.1	9.57	4.1e-17	646.9878	3	0.58	TLNDELEIIEGMKFDR	TLNDELEIIEGM(Oxidation)KFDR	Oxidation@217	16	V20130429-06_FTMSms2hcd	50.185	206	221	35.6	3.8e-11	3.9e-14	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[5]		P10809	CH60_HUMAN	HSPD1	7	21.1	9.57	4.1e-17	789.1160	3	-0.11	KPLVIIAEDVDGEALSTLVLNR	KPLVIIAEDVDGEALSTLVLNR		22	V20130429-06_FTMSms2hcd	64.815	269	290	49.5	5.7e-11	4.0e-13	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[5]		P10809	CH60_HUMAN	HSPD1	7	21.1	9.57	4.1e-17	1151.8101	4	15	TALLDAAGVASLLTTAEVVVTEIPKEEKDPGMGAMGGMGGGMGGGMF	TALLDAAGVASLLT(Phospho)TAEVVVTEIPKEEKDPGMGAMGGMGGGMGGGMF	Phospho@537|540|541|547	47	V20130429-06_FTMSms2hcd	77.443	527	573	14.7	2.9e-5	4.4e-8	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[5]		P10809	CH60_HUMAN	HSPD1	7	21.1	9.57	4.1e-17	921.6500	5	15	TALLDAAGVASLLTTAEVVVTEIPKEEKDPGMGAMGGMGGGMGGGMF	TALLDAAGVAS(Phospho)LLTTAEVVVTEIPKEEKDPGMGAMGGMGGGMGGGMF	Phospho@537|540|547	47	V20130429-06_FTMSms2hcd	77.464	527	573	12.9	1.7e-4	2.6e-7	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[6]		P08670	VIME_HUMAN	VIM	6	21.9	10.67	3.7e-19	981.5112	4	2.2	LHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR	LHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR		34	V20130429-06_FTMSms2hcd	57.455	237	270	57.5	3.7e-19	9.4e-22	1	53652.1	HUMAN	Vimentin
[6]		P08670	VIME_HUMAN	VIM	6	21.9	10.67	3.7e-19	794.4022	2	-0.10	TNEKVELQELNDR	TNEKVELQELNDR		13	V20130429-06_FTMSms2hcd	26.597	101	113	52.2	1.9e-10	2.3e-13	2	53652.1	HUMAN	Vimentin
[6]		P08670	VIME_HUMAN	VIM	6	21.9	10.67	3.7e-19	457.7325	2	-0.069	SYVTTSTR	SYVTTSTR		8	V20130429-06_FTMSms2hcd	11.532	29	36	21.8	2.0e-9	4.2e-12	1	53652.1	HUMAN	Vimentin
[6]		P08670	VIME_HUMAN	VIM	6	21.9	10.67	3.7e-19	748.3968	2	-0.0054	TYSLGSALRPSTSR	TYSLGSALRPSTSR		14	V20130429-06_FTMSms2hcd	30.505	37	50	36.0	3.8e-9	5.9e-12	1	53652.1	HUMAN	Vimentin
[6]		P08670	VIME_HUMAN	VIM	6	21.9	10.67	3.7e-19	513.9758	3	1.5	ILLAELEQLKGQGK	ILLAELEQLKGQGK		14	V20130429-06_FTMSms2hcd	45.371	130	143	48.0	1.1e-8	8.3e-11	1	53652.1	HUMAN	Vimentin
[6]		P08670	VIME_HUMAN	VIM	6	21.9	10.67	3.7e-19	1063.5372	2	0.91	LLQDSVDFSLADAINTEFK	LLQDSVDFSLADAINTEFK		19	V20130429-06_FTMSms2hcd	65.654	79	97	12.9	3.9e-4	4.9e-7	1	53652.1	HUMAN	Vimentin
[6-1]	0	P17661	DESM_HUMAN	DES	1	2.8	5.97	1.9e-10	794.4022	2	-0.10	TNEKVELQELNDR	TNEKVELQELNDR		13	V20130429-06_FTMSms2hcd	26.597	106	118	52.2	1.9e-10	2.3e-13	2	53536.2	HUMAN	Desmin
[7]		P12814	ACTN1_HUMAN	ACTN1	5	9.0	8.05	2.7e-14	669.9930	3	0.57	AIMTYVSSFYHAFSGAQK	AIMTYVSSFYHAFSGAQK		18	V20130429-06_FTMSms2hcd	61.118	237	254	34.0	2.7e-14	2.8e-17	2	103058.4	HUMAN	Alpha-actinin-1
[7]		P12814	ACTN1_HUMAN	ACTN1	5	9.0	8.05	2.7e-14	1012.4831	2	0.35	AIMTYVSSFYHAFSGAQK	AIM(Oxidation)TYVSSFYHAFSGAQK	Oxidation@239	18	V20130429-06_FTMSms2hcd	53.696	237	254	37.4	1.5e-13	1.5e-16	2	103058.4	HUMAN	Alpha-actinin-1
[7]		P12814	ACTN1_HUMAN	ACTN1	5	9.0	8.05	2.7e-14	685.0818	4	0.55	AIMTYVSSFYHAFSGAQKAETAANR	AIM(Oxidation)TYVSSFYHAFSGAQKAETAANR	Oxidation@239	25	V20130429-06_FTMSms2hcd	51.236	237	261	41.2	1.2e-12	1.2e-15	2	103058.4	HUMAN	Alpha-actinin-1
[7]		P12814	ACTN1_HUMAN	ACTN1	5	9.0	8.05	2.7e-14	909.4454	5	4.8	KHEAFESDLAAHQDRVEQIAAIAQELNELDYYDSPSVNAR	KHEAFESDLAAHQDRVEQIAAIAQELNELDYYDSPSVNAR		40	V20130429-06_FTMSms2hcd	60.459	436	475	34.1	2.1e-10	3.3e-13	1	103058.4	HUMAN	Alpha-actinin-1
[7]		P12814	ACTN1_HUMAN	ACTN1	5	9.0	8.05	2.7e-14	623.3418	3	-3.0	LLETIDQLYLEYAKR	LLETIDQLYLEYAKR		15	V20130429-06_FTMSms2hcd	58.243	503	517	24.6	2.4e-8	5.7e-11	1	103058.4	HUMAN	Alpha-actinin-1
[7-1]	0	O43707	ACTN4_HUMAN	ACTN4	3	2.7	8.05	2.7e-14	669.9930	3	0.57	AIMTYVSSFYHAFSGAQK	AIMTYVSSFYHAFSGAQK		18	V20130429-06_FTMSms2hcd	61.118	256	273	34.0	2.7e-14	2.8e-17	2	104854.9	HUMAN	Alpha-actinin-4
[7-1]	0	O43707	ACTN4_HUMAN	ACTN4	3	2.7	8.05	2.7e-14	1012.4831	2	0.35	AIMTYVSSFYHAFSGAQK	AIM(Oxidation)TYVSSFYHAFSGAQK	Oxidation@258	18	V20130429-06_FTMSms2hcd	53.696	256	273	37.4	1.5e-13	1.5e-16	2	104854.9	HUMAN	Alpha-actinin-4
[7-1]	0	O43707	ACTN4_HUMAN	ACTN4	3	2.7	8.05	2.7e-14	685.0818	4	0.55	AIMTYVSSFYHAFSGAQKAETAANR	AIM(Oxidation)TYVSSFYHAFSGAQKAETAANR	Oxidation@258	25	V20130429-06_FTMSms2hcd	51.236	256	280	41.2	1.2e-12	1.2e-15	2	104854.9	HUMAN	Alpha-actinin-4
[8]		P08238	HS90B_HUMAN	HSP90AB1	5	10.1	9.40	8.6e-17	996.8627	3	14	DLVVLLFETALLSSGFSLEDPQTHSNR	DLVVLLFETALLSSGFSLEDPQTHSNR		27	V20130429-06_FTMSms2hcd	77.903	653	679	45.2	8.6e-17	2.1e-19	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	5	10.1	9.40	8.6e-17	683.3680	2	-0.49	TLTLVDTGIGMTK	TLTLVDTGIGM(Oxidation)TK	Oxidation@93	13	V20130429-06_FTMSms2hcd	39.376	83	95	55.5	2.4e-15	3.8e-18	3	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	5	10.1	9.40	8.6e-17	973.3998	2	0.67	IEDVGSDEEDDSGKDKK	IEDVGS(Phospho)DEEDDSGKDKK	Phospho@255=44	17	V20130429-06_FTMSms2hcd	12.135	250	266	45.9	5.6e-13	8.8e-16	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	5	10.1	9.40	8.6e-17	571.2834	2	-0.090	LGIHEDSTNR	LGIHEDSTNR		10	V20130429-06_FTMSms2hcd	12.894	439	448	34.1	9.8e-11	1.6e-13	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8]		P08238	HS90B_HUMAN	HSP90AB1	5	10.1	9.40	8.6e-17	365.7264	2	-0.33	LSELLR	LSELLR		6	V20130429-06_FTMSms2hcd	26.113	451	456	20.1	0.026	4.1e-5	3	83264.9	HUMAN	Heat shock protein HSP 90-beta
[8-1]	0	P07900	HS90A_HUMAN	HSP90AA1	2	2.6	8.61	2.4e-15	683.3680	2	-0.49	TLTIVDTGIGMTK	TLTIVDTGIGM(Oxidation)TK	Oxidation@98	13	V20130429-06_FTMSms2hcd	39.376	88	100	55.5	2.4e-15	3.8e-18	3	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[8-1]	0	P07900	HS90A_HUMAN	HSP90AA1	2	2.6	8.61	2.4e-15	365.7264	2	-0.33	LSELLR	LSELLR		6	V20130429-06_FTMSms2hcd	26.113	459	464	20.1	0.026	4.1e-5	3	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[8-2]	0	Q58FG1	HS904_HUMAN	HSP90AA4P	1	3.1	8.61	2.4e-15	683.3680	2	-0.49	TLTIVDTGIGMTK	TLTIVDTGIGM(Oxidation)TK	Oxidation@38	13	V20130429-06_FTMSms2hcd	39.376	28	40	55.5	2.4e-15	3.8e-18	3	47712.3	HUMAN	Putative heat shock protein HSP 90-alpha A4
[8-3]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	1	4.5	7.34	5.6e-13	973.3998	2	0.67	IEDVGSDEEDDSGKDKK	IEDVGS(Phospho)DEEDDSGKDKK	Phospho@177=44	17	V20130429-06_FTMSms2hcd	12.135	172	188	45.9	5.6e-13	8.8e-16	2	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[9]		P06733	ENOA_HUMAN	ENO1	5	20.5	9.39	8.6e-17	1148.5731	2	0.53	SGETEDTFIADLVVGLCTGQIK	SGETEDTFIADLVVGLCTGQIK		22	V20130429-06_FTMSms2hcd	77.809	373	394	48.6	8.6e-17	1.0e-19	3	47169.4	HUMAN	Alpha-enolase
[9]		P06733	ENOA_HUMAN	ENO1	5	20.5	9.39	8.6e-17	995.8024	3	-0.50	SFIKDYPVVSIEDPFDQDDWGAWQK	SFIKDYPVVSIEDPFDQDDWGAWQK		25	V20130429-06_FTMSms2hcd	65.507	282	306	42.2	1.0e-14	9.7e-18	1	47169.4	HUMAN	Alpha-enolase
[9]		P06733	ENOA_HUMAN	ENO1	5	20.5	9.39	8.6e-17	731.3680	3	9.2	AGYTDKVVIGMDVAASEFFR	AGYTDKVVIGM(Oxidation)DVAASEFFR	Oxidation@244	20	V20130429-06_FTMSms2hcd	51.089	234	253	31.4	4.6e-10	5.2e-13	1	47169.4	HUMAN	Alpha-enolase
[9]		P06733	ENOA_HUMAN	ENO1	5	20.5	9.39	8.6e-17	713.3674	2	1.1	YISPDQLADLYK	YISPDQLADLYK		12	V20130429-06_FTMSms2hcd	48.644	270	281	34.5	5.5e-9	7.5e-12	1	47169.4	HUMAN	Alpha-enolase
[9]		P06733	ENOA_HUMAN	ENO1	5	20.5	9.39	8.6e-17	572.3112	2	-0.49	IGAEVYHNLK	IGAEVYHNLK		10	V20130429-06_FTMSms2hcd	22.906	184	193	22.7	1.8e-5	3.1e-8	1	47169.4	HUMAN	Alpha-enolase
[9-1]	0	P09104	ENOG_HUMAN	ENO2	1	5.1	9.39	8.6e-17	1148.5731	2	0.53	SGETEDTFIADLVVGLCTGQIK	SGETEDTFIADLVVGLCTGQIK		22	V20130429-06_FTMSms2hcd	77.809	373	394	48.6	8.6e-17	1.0e-19	3	47269.0	HUMAN	Gamma-enolase
[9-2]	0	P13929	ENOB_HUMAN	ENO3	1	5.1	9.39	8.6e-17	1148.5731	2	0.53	SGETEDTFIADLVVGLCTGQIK	SGETEDTFIADLVVGLCTGQIK		22	V20130429-06_FTMSms2hcd	77.809	373	394	48.6	8.6e-17	1.0e-19	3	46932.2	HUMAN	Beta-enolase
[10]		P07355	ANXA2_HUMAN	ANXA2	5	21.5	6.93	3.1e-12	860.9266	2	2.2	GLGTDEDSLIEIICSR	GLGTDEDSLIEIICSR		16	V20130429-06_FTMSms2hcd	66.378	120	135	52.3	3.1e-12	3.2e-15	2	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	5	21.5	6.93	3.1e-12	550.9978	3	-0.022	SALSGHLETVILGLLK	SALSGHLETVILGLLK		16	V20130429-06_FTMSms2hcd	69.782	89	104	43.9	4.7e-12	6.7e-14	2	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	5	21.5	6.93	3.1e-12	771.9281	2	0.21	GVDEVTIVNILTNR	GVDEVTIVNILTNR		14	V20130429-06_FTMSms2hcd	59.507	50	63	47.2	2.2e-10	5.2e-13	1	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	5	21.5	6.93	3.1e-12	536.2787	2	-0.17	MSTVHEILCK	M(Met-loss+Acetyl)STVHEILCK	Met-loss+Acetyl@1	10	V20130429-06_FTMSms2hcd	34.040	1	10	39.9	4.4e-10	8.1e-13	2	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	5	21.5	6.93	3.1e-12	485.7459	4	0.54	TDLEKDIISDTSGDFRK	TDLEKDIISDTSGDFRK		17	V20130429-06_FTMSms2hcd	40.629	153	169	34.4	2.0e-9	2.4e-12	2	38604.4	HUMAN	Annexin A2
[10-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	4	17.4	6.93	3.1e-12	860.9266	2	2.2	GLGTDEDSLIEIICSR	GLGTDEDSLIEIICSR		16	V20130429-06_FTMSms2hcd	66.378	120	135	52.3	3.1e-12	3.2e-15	2	38659.3	HUMAN	Putative annexin A2-like protein
[10-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	4	17.4	6.93	3.1e-12	550.9978	3	-0.022	SALSGHLETVILGLLK	SALSGHLETVILGLLK		16	V20130429-06_FTMSms2hcd	69.782	89	104	43.9	4.7e-12	6.7e-14	2	38659.3	HUMAN	Putative annexin A2-like protein
[10-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	4	17.4	6.93	3.1e-12	536.2787	2	-0.17	MSTVHEILCK	M(Met-loss+Acetyl)STVHEILCK	Met-loss+Acetyl@1	10	V20130429-06_FTMSms2hcd	34.040	1	10	39.9	4.4e-10	8.1e-13	2	38659.3	HUMAN	Putative annexin A2-like protein
[10-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	4	17.4	6.93	3.1e-12	485.7459	4	0.54	TDLEKDIISDTSGDFRK	TDLEKDIISDTSGDFRK		17	V20130429-06_FTMSms2hcd	40.629	153	169	34.4	2.0e-9	2.4e-12	2	38659.3	HUMAN	Putative annexin A2-like protein
[11]		P09651	ROA1_HUMAN	HNRNPA1	4	21.8	9.07	3.5e-16	591.4965	5	9.2	GFGFVTYATVEEVDAAMNARPHKVDGR	GFGFVTYATVEEVDAAM(Oxidation)NARPHKVDGR	Oxidation@72	27	V20130429-06_FTMSms2hcd	48.967	56	82	52.1	3.5e-16	3.8e-19	1	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[11]		P09651	ROA1_HUMAN	HNRNPA1	4	21.8	9.07	3.5e-16	892.9551	2	-2.0	LFIGGLSFETTDESLR	LFIGGLSFETTDESLR		16	V20130429-06_FTMSms2hcd	58.191	16	31	48.0	1.3e-12	1.6e-15	2	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[11]		P09651	ROA1_HUMAN	HNRNPA1	4	21.8	9.07	3.5e-16	571.0425	4	-0.77	GFAFVTFDDHDSVDKIVIQK	GFAFVTFDDHDSVDKIVIQK		20	V20130429-06_FTMSms2hcd	52.516	147	166	24.9	2.2e-7	2.8e-10	2	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[11]		P09651	ROA1_HUMAN	HNRNPA1	4	21.8	9.07	3.5e-16	847.8535	2	-0.22	NQGGYGGSSSSSSYGSGR	NQGGYGGSSSSSSYGSGR		18	V20130429-06_FTMSms2hcd	12.066	353	370	21.5	2.7e-7	3.9e-10	1	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[11-1]	0	Q32P51	RA1L2_HUMAN	HNRNPA1L2	2	11.2	7.14	1.3e-12	892.9551	2	-2.0	LFIGGLSFETTDESLR	LFIGGLSFETTDESLR		16	V20130429-06_FTMSms2hcd	58.191	16	31	48.0	1.3e-12	1.6e-15	2	34225.6	HUMAN	Heterogeneous nuclear ribonucleoprotein A1-like 2
[11-1]	0	Q32P51	RA1L2_HUMAN	HNRNPA1L2	2	11.2	7.14	1.3e-12	571.0425	4	-0.77	GFAFVTFDDHDSVDKIVIQK	GFAFVTFDDHDSVDKIVIQK		20	V20130429-06_FTMSms2hcd	52.516	147	166	24.9	2.2e-7	2.8e-10	2	34225.6	HUMAN	Heterogeneous nuclear ribonucleoprotein A1-like 2
[12]		P22626	ROA2_HUMAN	HNRNPA2B1	3	14.7	8.98	5.0e-16	956.4694	3	1.7	LFIGGLSFETTEESLRNYYEQWGK	LFIGGLSFETTEESLRNYYEQWGK		24	V20130429-06_FTMSms2hcd	69.529	23	46	58.2	5.0e-16	5.4e-19	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[12]		P22626	ROA2_HUMAN	HNRNPA2B1	3	14.7	8.98	5.0e-16	749.6248	4	-2.1	KLFIGGLSFETTEESLRNYYEQWGK	KLFIGGLSFETTEESLRNYYEQWGK		25	V20130429-06_FTMSms2hcd	65.119	22	46	44.5	8.1e-13	9.5e-16	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[12]		P22626	ROA2_HUMAN	HNRNPA2B1	3	14.7	8.98	5.0e-16	715.5851	4	-0.11	GFGFVTFSSMAEVDAAMAARPHSIDGR	GFGFVTFSSM(Oxidation)AEVDAAM(Oxidation)AARPHSIDGR	Oxidation@72;Oxidation@79	27	V20130429-06_FTMSms2hcd	51.771	63	89	35.9	4.8e-12	4.4e-15	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[13]		P07437	TBB5_HUMAN	TUBB	5	21.8	6.13	3.5e-11	696.3634	3	-0.53	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-06_FTMSms2hcd	58.084	104	122	37.6	3.5e-11	4.8e-14	5	49671.3	HUMAN	Tubulin beta chain
[13]		P07437	TBB5_HUMAN	TUBB	5	21.8	6.13	3.5e-11	782.2041	5	1.9	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRK	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLRK	Oxidation@233	36	V20130429-06_FTMSms2hcd	68.953	217	252	35.5	1.2e-10	2.5e-13	5	49671.3	HUMAN	Tubulin beta chain
[13]		P07437	TBB5_HUMAN	TUBB	5	21.8	6.13	3.5e-11	589.3011	3	-7.2	EIVHIQAGQCGNQIGAK	EIVHIQAGQCGNQIGAK		17	V20130429-06_FTMSms2hcd	29.700	3	19	29.5	1.7e-7	2.0e-10	6	49671.3	HUMAN	Tubulin beta chain
[13]		P07437	TBB5_HUMAN	TUBB	5	21.8	6.13	3.5e-11	539.2701	2	0.53	IREEYPDR	IREEYPDR		8	V20130429-06_FTMSms2hcd	12.122	155	162	35.9	2.9e-6	4.8e-9	8	49671.3	HUMAN	Tubulin beta chain
[13]		P07437	TBB5_HUMAN	TUBB	5	21.8	6.13	3.5e-11	943.5031	2	14	MAVTFIGNSTAIQELFK	M(Oxidation)AVTFIGNSTAIQELFK	Oxidation@363	17	V20130429-06_FTMSms2hcd	63.842	363	379	12.1	1.2e-4	2.1e-7	1	49671.3	HUMAN	Tubulin beta chain
[13-1]	0	P68371	TBB4B_HUMAN	TUBB4B	4	18.0	6.13	3.5e-11	696.3634	3	-0.53	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-06_FTMSms2hcd	58.084	104	122	37.6	3.5e-11	4.8e-14	5	49831.5	HUMAN	Tubulin beta-4B chain
[13-1]	0	P68371	TBB4B_HUMAN	TUBB4B	4	18.0	6.13	3.5e-11	782.2041	5	1.9	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRK	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLRK	Oxidation@233	36	V20130429-06_FTMSms2hcd	68.953	217	252	35.5	1.2e-10	2.5e-13	5	49831.5	HUMAN	Tubulin beta-4B chain
[13-1]	0	P68371	TBB4B_HUMAN	TUBB4B	4	18.0	6.13	3.5e-11	589.3011	3	-7.2	EIVHLQAGQCGNQIGAK	EIVHLQAGQCGNQIGAK		17	V20130429-06_FTMSms2hcd	29.700	3	19	29.5	1.7e-7	2.0e-10	6	49831.5	HUMAN	Tubulin beta-4B chain
[13-1]	0	P68371	TBB4B_HUMAN	TUBB4B	4	18.0	6.13	3.5e-11	539.2701	2	0.53	IREEYPDR	IREEYPDR		8	V20130429-06_FTMSms2hcd	12.122	155	162	35.9	2.9e-6	4.8e-9	8	49831.5	HUMAN	Tubulin beta-4B chain
[13-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	4	18.0	6.13	3.5e-11	696.3634	3	-0.53	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-06_FTMSms2hcd	58.084	104	122	37.6	3.5e-11	4.8e-14	5	49907.4	HUMAN	Tubulin beta-2A chain
[13-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	4	18.0	6.13	3.5e-11	782.2041	5	1.9	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRK	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLRK	Oxidation@233	36	V20130429-06_FTMSms2hcd	68.953	217	252	35.5	1.2e-10	2.5e-13	5	49907.4	HUMAN	Tubulin beta-2A chain
[13-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	4	18.0	6.13	3.5e-11	589.3011	3	-7.2	EIVHIQAGQCGNQIGAK	EIVHIQAGQCGNQIGAK		17	V20130429-06_FTMSms2hcd	29.700	3	19	29.5	1.7e-7	2.0e-10	6	49907.4	HUMAN	Tubulin beta-2A chain
[13-2]	0	Q13885	TBB2A_HUMAN	TUBB2A	4	18.0	6.13	3.5e-11	539.2701	2	0.53	IREEYPDR	IREEYPDR		8	V20130429-06_FTMSms2hcd	12.122	155	162	35.9	2.9e-6	4.8e-9	8	49907.4	HUMAN	Tubulin beta-2A chain
[13-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	4	18.0	6.13	3.5e-11	696.3634	3	-0.53	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-06_FTMSms2hcd	58.084	104	122	37.6	3.5e-11	4.8e-14	5	49953.5	HUMAN	Tubulin beta-2B chain
[13-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	4	18.0	6.13	3.5e-11	782.2041	5	1.9	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRK	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLRK	Oxidation@233	36	V20130429-06_FTMSms2hcd	68.953	217	252	35.5	1.2e-10	2.5e-13	5	49953.5	HUMAN	Tubulin beta-2B chain
[13-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	4	18.0	6.13	3.5e-11	589.3011	3	-7.2	EIVHIQAGQCGNQIGAK	EIVHIQAGQCGNQIGAK		17	V20130429-06_FTMSms2hcd	29.700	3	19	29.5	1.7e-7	2.0e-10	6	49953.5	HUMAN	Tubulin beta-2B chain
[13-3]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	4	18.0	6.13	3.5e-11	539.2701	2	0.53	IREEYPDR	IREEYPDR		8	V20130429-06_FTMSms2hcd	12.122	155	162	35.9	2.9e-6	4.8e-9	8	49953.5	HUMAN	Tubulin beta-2B chain
[13-4]	0	Q13509	TBB3_HUMAN	TUBB3	2	8.0	6.13	3.5e-11	696.3634	3	-0.53	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-06_FTMSms2hcd	58.084	104	122	37.6	3.5e-11	4.8e-14	5	50433.2	HUMAN	Tubulin beta-3 chain
[13-4]	0	Q13509	TBB3_HUMAN	TUBB3	2	8.0	6.13	3.5e-11	589.3011	3	-7.2	EIVHIQAGQCGNQIGAK	EIVHIQAGQCGNQIGAK		17	V20130429-06_FTMSms2hcd	29.700	3	19	29.5	1.7e-7	2.0e-10	6	50433.2	HUMAN	Tubulin beta-3 chain
[13-5]	0	P04350	TBB4A_HUMAN	TUBB4A	2	11.9	5.63	1.2e-10	782.2041	5	1.9	LTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRK	LTTPTYGDLNHLVSATM(Oxidation)SGVTTCLRFPGQLNADLRK	Oxidation@233	36	V20130429-06_FTMSms2hcd	68.953	217	252	35.5	1.2e-10	2.5e-13	5	49586.2	HUMAN	Tubulin beta-4A chain
[13-5]	0	P04350	TBB4A_HUMAN	TUBB4A	2	11.9	5.63	1.2e-10	589.3011	3	-7.2	EIVHLQAGQCGNQIGAK	EIVHLQAGQCGNQIGAK		17	V20130429-06_FTMSms2hcd	29.700	3	19	29.5	1.7e-7	2.0e-10	6	49586.2	HUMAN	Tubulin beta-4A chain
[13-6]	0	Q3ZCM7	TBB8_HUMAN	TUBB8	1	1.8	3.30	2.9e-6	539.2701	2	0.53	IREEYPDR	IREEYPDR		8	V20130429-06_FTMSms2hcd	12.122	155	162	35.9	2.9e-6	4.8e-9	8	49776.5	HUMAN	Tubulin beta-8 chain
[13-7]	0	Q9H4B7	TBB1_HUMAN	TUBB1	1	1.8	3.30	2.9e-6	539.2701	2	0.53	IREEYPDR	IREEYPDR		8	V20130429-06_FTMSms2hcd	12.122	155	162	35.9	2.9e-6	4.8e-9	8	50327.4	HUMAN	Tubulin beta-1 chain
[13-8]	0	A6NKZ8	YI016_HUMAN		1	2.2	3.30	2.9e-6	539.2701	2	0.53	IREEYPDR	IREEYPDR		8	V20130429-06_FTMSms2hcd	12.122	83	90	35.9	2.9e-6	4.8e-9	8	41775.5	HUMAN	Putative tubulin beta chain-like protein ENSP00000290377
[13-9]	0	A6NNZ2	TBB8B_HUMAN		1	1.8	3.30	2.9e-6	539.2701	2	0.53	IREEYPDR	IREEYPDR		8	V20130429-06_FTMSms2hcd	12.122	155	162	35.9	2.9e-6	4.8e-9	8	49573.1	HUMAN	Tubulin beta-8 chain B
[14]		P11142	HSP7C_HUMAN	HSPA8	4	8.0	7.62	1.7e-13	991.5099	2	7.4	TVTNAVVTVPAYFNDSQR	TVTNAVVTVPAYFNDSQR		18	V20130429-06_FTMSms2hcd	46.034	138	155	46.9	1.7e-13	2.2e-16	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[14]		P11142	HSP7C_HUMAN	HSPA8	4	8.0	7.62	1.7e-13	744.3555	2	1.7	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-06_FTMSms2hcd	34.624	37	49	41.3	6.7e-12	8.4e-15	6	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[14]		P11142	HSP7C_HUMAN	HSPA8	4	8.0	7.62	1.7e-13	627.3122	2	0.83	FEELNADLFR	FEELNADLFR		10	V20130429-06_FTMSms2hcd	48.541	302	311	25.2	4.9e-7	5.6e-10	2	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[14]		P11142	HSP7C_HUMAN	HSPA8	4	8.0	7.62	1.7e-13	614.8177	2	0.068	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-06_FTMSms2hcd	20.654	26	36	32.3	0.0021	3.2e-6	7	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[14-1]	0	P54652	HSP72_HUMAN	HSPA2	3	5.3	6.75	6.7e-12	744.3555	2	1.7	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-06_FTMSms2hcd	34.624	38	50	41.3	6.7e-12	8.4e-15	6	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[14-1]	0	P54652	HSP72_HUMAN	HSPA2	3	5.3	6.75	6.7e-12	627.3122	2	0.83	FEELNADLFR	FEELNADLFR		10	V20130429-06_FTMSms2hcd	48.541	305	314	25.2	4.9e-7	5.6e-10	2	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[14-1]	0	P54652	HSP72_HUMAN	HSPA2	3	5.3	6.75	6.7e-12	614.8177	2	0.068	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-06_FTMSms2hcd	20.654	27	37	32.3	0.0021	3.2e-6	7	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[14-2]	1	P11021	GRP78_HUMAN	HSPA5	2	4.4	9.49	5.7e-17	1083.0015	2	1.7	IEIESFYEGEDFSETLTR	IEIESFYEGEDFSETLTR		18	V20130429-06_FTMSms2hcd	56.338	307	324	51.6	5.7e-17	5.4e-20	1	72333.5	HUMAN	78 kDa glucose-regulated protein
[14-2]	1	P11021	GRP78_HUMAN	HSPA5	2	4.4	9.49	5.7e-17	614.8177	2	0.068	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-06_FTMSms2hcd	20.654	50	60	32.3	0.0021	3.2e-6	7	72333.5	HUMAN	78 kDa glucose-regulated protein
[14-3]	0	P08107	HSP71_HUMAN	HSPA1A	2	3.7	6.75	6.7e-12	744.3555	2	1.7	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-06_FTMSms2hcd	34.624	37	49	41.3	6.7e-12	8.4e-15	6	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[14-3]	0	P08107	HSP71_HUMAN	HSPA1A	2	3.7	6.75	6.7e-12	614.8177	2	0.068	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-06_FTMSms2hcd	20.654	26	36	32.3	0.0021	3.2e-6	7	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[14-4]	0	P17066	HSP76_HUMAN	HSPA6	2	3.7	6.75	6.7e-12	744.3555	2	1.7	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-06_FTMSms2hcd	34.624	39	51	41.3	6.7e-12	8.4e-15	6	71028.7	HUMAN	Heat shock 70 kDa protein 6
[14-4]	0	P17066	HSP76_HUMAN	HSPA6	2	3.7	6.75	6.7e-12	614.8177	2	0.068	VEILANDQGNR	VEILANDQGNR		11	V20130429-06_FTMSms2hcd	20.654	28	38	32.3	0.0021	3.2e-6	7	71028.7	HUMAN	Heat shock 70 kDa protein 6
[14-5]	0	P34931	HS71L_HUMAN	HSPA1L	2	3.7	6.75	6.7e-12	744.3555	2	1.7	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-06_FTMSms2hcd	34.624	39	51	41.3	6.7e-12	8.4e-15	6	70375.6	HUMAN	Heat shock 70 kDa protein 1-like
[14-5]	0	P34931	HS71L_HUMAN	HSPA1L	2	3.7	6.75	6.7e-12	614.8177	2	0.068	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-06_FTMSms2hcd	20.654	28	38	32.3	0.0021	3.2e-6	7	70375.6	HUMAN	Heat shock 70 kDa protein 1-like
[14-6]	0	P48741	HSP77_HUMAN	HSPA7	2	6.5	6.75	6.7e-12	744.3555	2	1.7	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-06_FTMSms2hcd	34.624	39	51	41.3	6.7e-12	8.4e-15	6	40244.8	HUMAN	Putative heat shock 70 kDa protein 7
[14-6]	0	P48741	HSP77_HUMAN	HSPA7	2	6.5	6.75	6.7e-12	614.8177	2	0.068	VEILANDQGNR	VEILANDQGNR		11	V20130429-06_FTMSms2hcd	20.654	28	38	32.3	0.0021	3.2e-6	7	40244.8	HUMAN	Putative heat shock 70 kDa protein 7
[15]		Q15366	PCBP2_HUMAN	PCBP2	3	17.3	7.33	5.6e-13	1115.6006	3	1.9	IANPVEGSTDRQVTITGSAASISLAQYLINVR	IANPVEGSTDRQVTITGSAASISLAQYLINVR		32	V20130429-06_FTMSms2hcd	64.562	323	354	46.3	5.6e-13	1.8e-15	1	38580.4	HUMAN	Poly(rC)-binding protein 2
[15]		Q15366	PCBP2_HUMAN	PCBP2	3	17.3	7.33	5.6e-13	846.6766	4	0.72	AFAMIIDKLEEDISSSMTNSTAASRPPVTLR	AFAM(Oxidation)IIDKLEEDISSSM(Oxidation)TNSTAASRPPVTLR	Oxidation@74;Oxidation@87	31	V20130429-06_FTMSms2hcd	63.321	71	101	45.9	4.0e-12	5.2e-15	1	38580.4	HUMAN	Poly(rC)-binding protein 2
[15]		Q15366	PCBP2_HUMAN	PCBP2	3	17.3	7.33	5.6e-13	735.7460	3	-0.14	QVTITGSAASISLAQYLINVR	QVTITGSAASISLAQYLINVR		21	V20130429-06_FTMSms2hcd	66.485	334	354	29.4	5.9e-10	2.2e-12	1	38580.4	HUMAN	Poly(rC)-binding protein 2
[16]		P62937	PPIA_HUMAN	PPIA	4	38.8	8.28	1.0e-14	917.4400	3	1.1	HTGPGILSMANAGPNTNGSQFFICTAK	HTGPGILSM(Oxidation)ANAGPNTNGSQFFICTAK	Oxidation@100	27	V20130429-06_FTMSms2hcd	48.001	92	118	52.8	1.0e-14	9.5e-18	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[16]		P62937	PPIA_HUMAN	PPIA	4	38.8	8.28	1.0e-14	779.3635	2	0.56	IIPGFMCQGGDFTR	IIPGFM(Oxidation)CQGGDFTR	Oxidation@61	14	V20130429-06_FTMSms2hcd	42.982	56	69	51.0	1.2e-10	1.4e-13	2	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[16]		P62937	PPIA_HUMAN	PPIA	4	38.8	8.28	1.0e-14	460.5901	3	-0.86	VSFELFADKVPK	VSFELFADKVPK		12	V20130429-06_FTMSms2hcd	47.414	20	31	21.4	5.1e-5	1.1e-7	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[16]		P62937	PPIA_HUMAN	PPIA	4	38.8	8.28	1.0e-14	595.8100	2	3.5	KITIADCGQLE	KITIADCGQLE		11	V20130429-06_FTMSms2hcd	36.901	155	165	16.0	0.0020	3.0e-6	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[16-1]	0	Q9Y536	PAL4A_HUMAN	PPIAL4A	1	8.5	6.08	1.2e-10	779.3635	2	0.56	IIPGFMCQGGDFTR	IIPGFM(Oxidation)CQGGDFTR	Oxidation@61	14	V20130429-06_FTMSms2hcd	42.982	56	69	51.0	1.2e-10	1.4e-13	2	18182.0	HUMAN	Peptidyl-prolyl cis-trans isomerase A-like 4A/B/C
[17]		P02765	FETUA_HUMAN	AHSG	3	3.5	6.72	7.7e-12	744.7873	2	0.063	CDSSPDSAEDVRK	CDSSPDS(Phospho)AEDVRK	Phospho@138=24	13	V20130429-06_FTMSms2hcd	11.222	132	144	42.2	7.7e-12	2.0e-14	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[17]		P02765	FETUA_HUMAN	AHSG	3	3.5	6.72	7.7e-12	704.8044	2	0.44	CDSSPDSAEDVRK	CDSSPDSAEDVRK		13	V20130429-06_FTMSms2hcd	9.876	132	144	35.8	2.5e-11	4.2e-14	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[17]		P02765	FETUA_HUMAN	AHSG	3	3.5	6.72	7.7e-12	640.7559	2	-1.1	CDSSPDSAEDVR	CDSSPDSAEDVR		12	V20130429-06_FTMSms2hcd	13.216	132	143	32.8	3.0e-9	7.4e-12	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[18]		P68363	TBA1B_HUMAN	TUBA1B	3	10.9	7.16	1.2e-12	1004.4603	2	10	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-06_FTMSms2hcd	51.076	41	60	49.6	1.2e-12	1.2e-15	5	50152.1	HUMAN	Tubulin alpha-1B chain
[18]		P68363	TBA1B_HUMAN	TUBA1B	3	10.9	7.16	1.2e-12	851.4649	2	9.8	AVFVDLEPTVIDEVR	AVFVDLEPTVIDEVR		15	V20130429-06_FTMSms2hcd	57.399	65	79	34.9	1.8e-10	3.7e-13	3	50152.1	HUMAN	Tubulin alpha-1B chain
[18]		P68363	TBA1B_HUMAN	TUBA1B	3	10.9	7.16	1.2e-12	744.4437	2	0.64	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-06_FTMSms2hcd	67.618	230	243	41.4	3.1e-9	1.8e-11	5	50152.1	HUMAN	Tubulin alpha-1B chain
[18-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	3	10.9	7.16	1.2e-12	1004.4603	2	10	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-06_FTMSms2hcd	51.076	41	60	49.6	1.2e-12	1.2e-15	5	49895.8	HUMAN	Tubulin alpha-1C chain
[18-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	3	10.9	7.16	1.2e-12	851.4649	2	9.8	AVFVDLEPTVIDEVR	AVFVDLEPTVIDEVR		15	V20130429-06_FTMSms2hcd	57.399	65	79	34.9	1.8e-10	3.7e-13	3	49895.8	HUMAN	Tubulin alpha-1C chain
[18-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	3	10.9	7.16	1.2e-12	744.4437	2	0.64	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-06_FTMSms2hcd	67.618	230	243	41.4	3.1e-9	1.8e-11	5	49895.8	HUMAN	Tubulin alpha-1C chain
[18-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	2	7.8	7.16	1.2e-12	1004.4603	2	10	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-06_FTMSms2hcd	51.076	41	60	49.6	1.2e-12	1.2e-15	5	50136.1	HUMAN	Tubulin alpha-1A chain
[18-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	2	7.8	7.16	1.2e-12	851.4649	2	9.8	AVFVDLEPTVIDEVR	AVFVDLEPTVIDEVR		15	V20130429-06_FTMSms2hcd	57.399	65	79	34.9	1.8e-10	3.7e-13	3	50136.1	HUMAN	Tubulin alpha-1A chain
[18-3]	0	Q13748	TBA3C_HUMAN	TUBA3C	1	4.4	7.16	1.2e-12	1004.4603	2	10	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-06_FTMSms2hcd	51.076	41	60	49.6	1.2e-12	1.2e-15	5	49960.0	HUMAN	Tubulin alpha-3C/D chain
[18-4]	0	Q6PEY2	TBA3E_HUMAN	TUBA3E	1	4.4	7.16	1.2e-12	1004.4603	2	10	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-06_FTMSms2hcd	51.076	41	60	49.6	1.2e-12	1.2e-15	5	49859.0	HUMAN	Tubulin alpha-3E chain
[18-5]	0	P68366	TBA4A_HUMAN	TUBA4A	1	3.1	5.32	3.1e-9	744.4437	2	0.64	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-06_FTMSms2hcd	67.618	230	243	41.4	3.1e-9	1.8e-11	5	49924.9	HUMAN	Tubulin alpha-4A chain
[18-6]	0	Q9H853	TBA4B_HUMAN	TUBA4B	1	5.8	5.32	3.1e-9	744.4437	2	0.64	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-06_FTMSms2hcd	67.618	169	182	41.4	3.1e-9	1.8e-11	5	27551.5	HUMAN	Putative tubulin-like protein alpha-4B
[18-7]	0	Q9NY65	TBA8_HUMAN	TUBA8	1	3.1	5.32	3.1e-9	744.4437	2	0.64	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-06_FTMSms2hcd	67.618	230	243	41.4	3.1e-9	1.8e-11	5	50094.0	HUMAN	Tubulin alpha-8 chain
[19]		Q16777	H2A2C_HUMAN	HIST2H2AC	4	49.6	7.02	2.2e-12	983.8532	3	2.0	VGAGAPVYMAAVLEYLTAEILELAGNAAR	VGAGAPVYM(Oxidation)AAVLEYLTAEILELAGNAAR	Oxidation@52	29	V20130429-06_FTMSms2hcd	78.154	44	72	48.6	2.2e-12	4.8e-15	2	13988.5	HUMAN	Histone H2A type 2-C
[19]		Q16777	H2A2C_HUMAN	HIST2H2AC	4	49.6	7.02	2.2e-12	966.0892	2	1.2	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-06_FTMSms2hcd	65.481	101	119	29.8	1.2e-9	3.4e-11	10	13988.5	HUMAN	Histone H2A type 2-C
[19]		Q16777	H2A2C_HUMAN	HIST2H2AC	4	49.6	7.02	2.2e-12	425.7669	2	0.91	HLQLAIR	HLQLAIR		7	V20130429-06_FTMSms2hcd	25.980	83	89	12.4	1.2e-4	1.1e-6	14	13988.5	HUMAN	Histone H2A type 2-C
[19]		Q16777	H2A2C_HUMAN	HIST2H2AC	4	49.6	7.02	2.2e-12	472.7691	2	-0.32	AGLQFPVGR	AGLQFPVGR		9	V20130429-06_FTMSms2hcd	36.500	22	30	28.2	7.2e-4	1.2e-6	15	13988.5	HUMAN	Histone H2A type 2-C
[19-1]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	4	49.2	7.02	2.2e-12	983.8532	3	2.0	VGAGAPVYMAAVLEYLTAEILELAGNAAR	VGAGAPVYM(Oxidation)AAVLEYLTAEILELAGNAAR	Oxidation@52	29	V20130429-06_FTMSms2hcd	78.154	44	72	48.6	2.2e-12	4.8e-15	2	14095.6	HUMAN	Histone H2A type 2-A
[19-1]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	4	49.2	7.02	2.2e-12	966.0892	2	1.2	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-06_FTMSms2hcd	65.481	101	119	29.8	1.2e-9	3.4e-11	10	14095.6	HUMAN	Histone H2A type 2-A
[19-1]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	4	49.2	7.02	2.2e-12	425.7669	2	0.91	HLQLAIR	HLQLAIR		7	V20130429-06_FTMSms2hcd	25.980	83	89	12.4	1.2e-4	1.1e-6	14	14095.6	HUMAN	Histone H2A type 2-A
[19-1]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	4	49.2	7.02	2.2e-12	472.7691	2	-0.32	AGLQFPVGR	AGLQFPVGR		9	V20130429-06_FTMSms2hcd	36.500	22	30	28.2	7.2e-4	1.2e-6	15	14095.6	HUMAN	Histone H2A type 2-A
[19-2]	0	P04908	H2A1B_HUMAN	HIST1H2AB	3	26.9	4.52	1.2e-9	966.0892	2	1.2	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-06_FTMSms2hcd	65.481	101	119	29.8	1.2e-9	3.4e-11	10	14135.6	HUMAN	Histone H2A type 1-B/E
[19-2]	0	P04908	H2A1B_HUMAN	HIST1H2AB	3	26.9	4.52	1.2e-9	425.7669	2	0.91	HLQLAIR	HLQLAIR		7	V20130429-06_FTMSms2hcd	25.980	83	89	12.4	1.2e-4	1.1e-6	14	14135.6	HUMAN	Histone H2A type 1-B/E
[19-2]	0	P04908	H2A1B_HUMAN	HIST1H2AB	3	26.9	4.52	1.2e-9	472.7691	2	-0.32	AGLQFPVGR	AGLQFPVGR		9	V20130429-06_FTMSms2hcd	36.500	22	30	28.2	7.2e-4	1.2e-6	15	14135.6	HUMAN	Histone H2A type 1-B/E
[19-3]	0	P0C0S8	H2A1_HUMAN	HIST1H2AG	3	26.9	4.52	1.2e-9	966.0892	2	1.2	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-06_FTMSms2hcd	65.481	101	119	29.8	1.2e-9	3.4e-11	10	14091.6	HUMAN	Histone H2A type 1
[19-3]	0	P0C0S8	H2A1_HUMAN	HIST1H2AG	3	26.9	4.52	1.2e-9	425.7669	2	0.91	HLQLAIR	HLQLAIR		7	V20130429-06_FTMSms2hcd	25.980	83	89	12.4	1.2e-4	1.1e-6	14	14091.6	HUMAN	Histone H2A type 1
[19-3]	0	P0C0S8	H2A1_HUMAN	HIST1H2AG	3	26.9	4.52	1.2e-9	472.7691	2	-0.32	AGLQFPVGR	AGLQFPVGR		9	V20130429-06_FTMSms2hcd	36.500	22	30	28.2	7.2e-4	1.2e-6	15	14091.6	HUMAN	Histone H2A type 1
[19-4]	0	P20671	H2A1D_HUMAN	HIST1H2AD	3	26.9	4.52	1.2e-9	966.0892	2	1.2	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-06_FTMSms2hcd	65.481	101	119	29.8	1.2e-9	3.4e-11	10	14107.6	HUMAN	Histone H2A type 1-D
[19-4]	0	P20671	H2A1D_HUMAN	HIST1H2AD	3	26.9	4.52	1.2e-9	425.7669	2	0.91	HLQLAIR	HLQLAIR		7	V20130429-06_FTMSms2hcd	25.980	83	89	12.4	1.2e-4	1.1e-6	14	14107.6	HUMAN	Histone H2A type 1-D
[19-4]	0	P20671	H2A1D_HUMAN	HIST1H2AD	3	26.9	4.52	1.2e-9	472.7691	2	-0.32	AGLQFPVGR	AGLQFPVGR		9	V20130429-06_FTMSms2hcd	36.500	22	30	28.2	7.2e-4	1.2e-6	15	14107.6	HUMAN	Histone H2A type 1-D
[19-5]	0	Q7L7L0	H2A3_HUMAN	HIST3H2A	3	26.9	4.52	1.2e-9	966.0892	2	1.2	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-06_FTMSms2hcd	65.481	101	119	29.8	1.2e-9	3.4e-11	10	14121.6	HUMAN	Histone H2A type 3
[19-5]	0	Q7L7L0	H2A3_HUMAN	HIST3H2A	3	26.9	4.52	1.2e-9	425.7669	2	0.91	HLQLAIR	HLQLAIR		7	V20130429-06_FTMSms2hcd	25.980	83	89	12.4	1.2e-4	1.1e-6	14	14121.6	HUMAN	Histone H2A type 3
[19-5]	0	Q7L7L0	H2A3_HUMAN	HIST3H2A	3	26.9	4.52	1.2e-9	472.7691	2	-0.32	AGLQFPVGR	AGLQFPVGR		9	V20130429-06_FTMSms2hcd	36.500	22	30	28.2	7.2e-4	1.2e-6	15	14121.6	HUMAN	Histone H2A type 3
[19-6]	0	Q93077	H2A1C_HUMAN	HIST1H2AC	3	26.9	4.52	1.2e-9	966.0892	2	1.2	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-06_FTMSms2hcd	65.481	101	119	29.8	1.2e-9	3.4e-11	10	14105.6	HUMAN	Histone H2A type 1-C
[19-6]	0	Q93077	H2A1C_HUMAN	HIST1H2AC	3	26.9	4.52	1.2e-9	425.7669	2	0.91	HLQLAIR	HLQLAIR		7	V20130429-06_FTMSms2hcd	25.980	83	89	12.4	1.2e-4	1.1e-6	14	14105.6	HUMAN	Histone H2A type 1-C
[19-6]	0	Q93077	H2A1C_HUMAN	HIST1H2AC	3	26.9	4.52	1.2e-9	472.7691	2	-0.32	AGLQFPVGR	AGLQFPVGR		9	V20130429-06_FTMSms2hcd	36.500	22	30	28.2	7.2e-4	1.2e-6	15	14105.6	HUMAN	Histone H2A type 1-C
[19-7]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	3	27.3	4.52	1.2e-9	966.0892	2	1.2	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-06_FTMSms2hcd	65.481	101	119	29.8	1.2e-9	3.4e-11	10	13906.4	HUMAN	Histone H2A type 1-H
[19-7]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	3	27.3	4.52	1.2e-9	425.7669	2	0.91	HLQLAIR	HLQLAIR		7	V20130429-06_FTMSms2hcd	25.980	83	89	12.4	1.2e-4	1.1e-6	14	13906.4	HUMAN	Histone H2A type 1-H
[19-7]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	3	27.3	4.52	1.2e-9	472.7691	2	-0.32	AGLQFPVGR	AGLQFPVGR		9	V20130429-06_FTMSms2hcd	36.500	22	30	28.2	7.2e-4	1.2e-6	15	13906.4	HUMAN	Histone H2A type 1-H
[19-8]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	3	27.3	4.52	1.2e-9	966.0892	2	1.2	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-06_FTMSms2hcd	65.481	101	119	29.8	1.2e-9	3.4e-11	10	13936.4	HUMAN	Histone H2A type 1-J
[19-8]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	3	27.3	4.52	1.2e-9	425.7669	2	0.91	HLQLAIR	HLQLAIR		7	V20130429-06_FTMSms2hcd	25.980	83	89	12.4	1.2e-4	1.1e-6	14	13936.4	HUMAN	Histone H2A type 1-J
[19-8]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	3	27.3	4.52	1.2e-9	472.7691	2	-0.32	AGLQFPVGR	AGLQFPVGR		9	V20130429-06_FTMSms2hcd	36.500	22	30	28.2	7.2e-4	1.2e-6	15	13936.4	HUMAN	Histone H2A type 1-J
[19-9]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	3	27.1	4.52	1.2e-9	966.0892	2	1.2	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-06_FTMSms2hcd	65.481	101	119	29.8	1.2e-9	3.4e-11	10	14019.5	HUMAN	Histone H2A.J
[19-9]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	3	27.1	4.52	1.2e-9	425.7669	2	0.91	HLQLAIR	HLQLAIR		7	V20130429-06_FTMSms2hcd	25.980	83	89	12.4	1.2e-4	1.1e-6	14	14019.5	HUMAN	Histone H2A.J
[19-9]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	3	27.1	4.52	1.2e-9	472.7691	2	-0.32	AGLQFPVGR	AGLQFPVGR		9	V20130429-06_FTMSms2hcd	36.500	22	30	28.2	7.2e-4	1.2e-6	15	14019.5	HUMAN	Histone H2A.J
[19-10]	0	P0C0S5	H2AZ_HUMAN	H2AFZ	2	12.5	1.67	1.2e-4	425.7669	2	0.91	HLQLAIR	HLQLAIR		7	V20130429-06_FTMSms2hcd	25.980	86	92	12.4	1.2e-4	1.1e-6	14	13552.8	HUMAN	Histone H2A.Z
[19-10]	0	P0C0S5	H2AZ_HUMAN	H2AFZ	2	12.5	1.67	1.2e-4	472.7691	2	-0.32	AGLQFPVGR	AGLQFPVGR		9	V20130429-06_FTMSms2hcd	36.500	24	32	28.2	7.2e-4	1.2e-6	15	13552.8	HUMAN	Histone H2A.Z
[19-11]	0	P16104	H2AX_HUMAN	H2AFX	2	11.2	1.67	1.2e-4	425.7669	2	0.91	HLQLAIR	HLQLAIR		7	V20130429-06_FTMSms2hcd	25.980	83	89	12.4	1.2e-4	1.1e-6	14	15144.7	HUMAN	Histone H2A.x
[19-11]	0	P16104	H2AX_HUMAN	H2AFX	2	11.2	1.67	1.2e-4	472.7691	2	-0.32	AGLQFPVGR	AGLQFPVGR		9	V20130429-06_FTMSms2hcd	36.500	22	30	28.2	7.2e-4	1.2e-6	15	15144.7	HUMAN	Histone H2A.x
[19-12]	0	Q71UI9	H2AV_HUMAN	H2AFV	2	12.5	1.67	1.2e-4	425.7669	2	0.91	HLQLAIR	HLQLAIR		7	V20130429-06_FTMSms2hcd	25.980	86	92	12.4	1.2e-4	1.1e-6	14	13508.8	HUMAN	Histone H2A.V
[19-12]	0	Q71UI9	H2AV_HUMAN	H2AFV	2	12.5	1.67	1.2e-4	472.7691	2	-0.32	AGLQFPVGR	AGLQFPVGR		9	V20130429-06_FTMSms2hcd	36.500	24	32	28.2	7.2e-4	1.2e-6	15	13508.8	HUMAN	Histone H2A.V
[19-13]	0	Q96QV6	H2A1A_HUMAN	HIST1H2AA	2	12.2	1.67	1.2e-4	425.7669	2	0.91	HLQLAIR	HLQLAIR		7	V20130429-06_FTMSms2hcd	25.980	83	89	12.4	1.2e-4	1.1e-6	14	14233.6	HUMAN	Histone H2A type 1-A
[19-13]	0	Q96QV6	H2A1A_HUMAN	HIST1H2AA	2	12.2	1.67	1.2e-4	472.7691	2	-0.32	AGLQFPVGR	AGLQFPVGR		9	V20130429-06_FTMSms2hcd	36.500	22	30	28.2	7.2e-4	1.2e-6	15	14233.6	HUMAN	Histone H2A type 1-A
[19-14]	0	Q8IUE6	H2A2B_HUMAN	HIST2H2AB	1	6.9	1.24	7.2e-4	472.7691	2	-0.32	AGLQFPVGR	AGLQFPVGR		9	V20130429-06_FTMSms2hcd	36.500	22	30	28.2	7.2e-4	1.2e-6	15	13995.4	HUMAN	Histone H2A type 2-B
[20]		Q13268	DHRS2_HUMAN	DHRS2	3	16.7	8.35	7.4e-15	887.5093	3	-0.019	RGAVILVSSIAAYNPVVALGVYNVSK	RGAVILVSSIAAYNPVVALGVYNVSK		26	V20130429-06_FTMSms2hcd	68.579	142	167	43.1	7.4e-15	8.7e-17	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[20]		Q13268	DHRS2_HUMAN	DHRS2	3	16.7	8.35	7.4e-15	835.4799	3	5.1	GAVILVSSIAAYNPVVALGVYNVSK	GAVILVSSIAAYNPVVALGVYNVSK		25	V20130429-06_FTMSms2hcd	74.076	143	167	31.6	5.3e-14	5.1e-16	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[20]		Q13268	DHRS2_HUMAN	DHRS2	3	16.7	8.35	7.4e-15	833.9659	2	18	LQGEGLSVAGIVCHVGK	LQGEGLSVAGIVCHVGK		17	V20130429-06_FTMSms2hcd	34.343	58	74	15.4	0.032	8.7e-5	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[21]		P13639	EF2_HUMAN	EEF2	3	7.9	6.85	4.4e-12	785.0786	3	1.1	GVQYLNEIKDSVVAGFQWATK	GVQYLNEIKDSVVAGFQWATK		21	V20130429-06_FTMSms2hcd	68.446	668	688	48.0	4.4e-12	7.0e-15	1	95339.0	HUMAN	Elongation factor 2
[21]		P13639	EF2_HUMAN	EEF2	3	7.9	6.85	4.4e-12	849.7736	3	3.4	STAISLFYELSENDLNFIKQSK	STAISLFYELSENDLNFIKQSK		22	V20130429-06_FTMSms2hcd	72.641	72	93	32.0	3.7e-11	5.6e-14	1	95339.0	HUMAN	Elongation factor 2
[21]		P13639	EF2_HUMAN	EEF2	3	7.9	6.85	4.4e-12	901.4771	3	2.1	YVEPIEDVPCGNIVGLVGVDQFLVK	YVEPIEDVPCGNIVGLVGVDQFLVK		25	V20130429-06_FTMSms2hcd	75.109	457	481	21.1	3.5e-7	6.8e-10	1	95339.0	HUMAN	Elongation factor 2
[22]		P62805	H4_HUMAN	HIST1H4A	3	30.1	6.03	1.5e-10	489.6064	3	0.74	TVTAMDVVYALKR	TVTAMDVVYALKR		13	V20130429-06_FTMSms2hcd	48.846	81	93	24.0	1.5e-10	3.5e-13	1	11367.4	HUMAN	Histone H4
[22]		P62805	H4_HUMAN	HIST1H4A	3	30.1	6.03	1.5e-10	527.0315	4	0.76	VFLENVIRDAVTYTEHAK	VFLENVIRDAVTYTEHAK		18	V20130429-06_FTMSms2hcd	62.873	61	78	27.6	4.0e-10	6.1e-13	1	11367.4	HUMAN	Histone H4
[22]		P62805	H4_HUMAN	HIST1H4A	3	30.1	6.03	1.5e-10	494.9381	3	0.86	TVTAMDVVYALKR	TVTAM(Oxidation)DVVYALKR	Oxidation@85	13	V20130429-06_FTMSms2hcd	40.591	81	93	40.6	7.3e-9	1.7e-11	1	11367.4	HUMAN	Histone H4
[23]		P23528	COF1_HUMAN	CFL1	3	28.9	7.17	1.1e-12	1021.5377	3	1.7	NIILEEGKEILVGDVGQTVDDPYATFVK	NIILEEGKEILVGDVGQTVDDPYATFVK		28	V20130429-06_FTMSms2hcd	64.501	46	73	43.8	1.1e-12	2.4e-15	1	18502.7	HUMAN	Cofilin-1
[23]		P23528	COF1_HUMAN	CFL1	3	28.9	7.17	1.1e-12	664.0289	3	1.9	KEDLVFIFWAPESAPLK	KEDLVFIFWAPESAPLK		17	V20130429-06_FTMSms2hcd	65.761	96	112	20.6	1.2e-8	2.8e-11	2	18502.7	HUMAN	Cofilin-1
[23]		P23528	COF1_HUMAN	CFL1	3	28.9	7.17	1.1e-12	778.7522	3	1.7	ESKKEDLVFIFWAPESAPLK	ESKKEDLVFIFWAPESAPLK		20	V20130429-06_FTMSms2hcd	61.517	93	112	26.9	9.0e-8	1.9e-10	2	18502.7	HUMAN	Cofilin-1
[23-1]	0	Q9Y281	COF2_HUMAN	CFL2	2	12.0	3.69	1.2e-8	664.0289	3	1.9	KEDLVFIFWAPESAPLK	KEDLVFIFWAPESAPLK		17	V20130429-06_FTMSms2hcd	65.761	96	112	20.6	1.2e-8	2.8e-11	2	18736.8	HUMAN	Cofilin-2
[23-1]	0	Q9Y281	COF2_HUMAN	CFL2	2	12.0	3.69	1.2e-8	778.7522	3	1.7	ESKKEDLVFIFWAPESAPLK	ESKKEDLVFIFWAPESAPLK		20	V20130429-06_FTMSms2hcd	61.517	93	112	26.9	9.0e-8	1.9e-10	2	18736.8	HUMAN	Cofilin-2
[24]		P30101	PDIA3_HUMAN	PDIA3	2	9.9	8.51	3.8e-15	859.1074	3	1.5	TFSHELSDFGLESTAGEIPVVAIR	TFSHELSDFGLESTAGEIPVVAIR		24	V20130429-06_FTMSms2hcd	60.326	306	329	41.8	3.8e-15	4.8e-18	1	56782.9	HUMAN	Protein disulfide-isomerase A3
[24]		P30101	PDIA3_HUMAN	PDIA3	2	9.9	8.51	3.8e-15	980.1327	3	1.8	FISDKDASIVGFFDDSFSEAHSEFLK	FISDKDASIVGFFDDSFSEAHSEFLK		26	V20130429-06_FTMSms2hcd	67.980	148	173	45.3	1.8e-14	1.7e-17	1	56782.9	HUMAN	Protein disulfide-isomerase A3
[25]		P19338	NUCL_HUMAN	NCL	2	6.3	8.70	1.7e-15	653.3134	4	0.94	GYAFIEFASFEDAKEALNSCNKR	GYAFIEFASFEDAKEALNSCNKR		23	V20130429-06_FTMSms2hcd	59.310	524	546	42.8	1.7e-15	1.6e-18	1	76615.0	HUMAN	Nucleolin
[25]		P19338	NUCL_HUMAN	NCL	2	6.3	8.70	1.7e-15	1251.1382	2	1.4	TLVLSNLSYSATEETLQEVFEK	TLVLSNLSYSATEETLQEVFEK		22	V20130429-06_FTMSms2hcd	70.950	487	508	47.6	1.3e-13	1.7e-16	1	76615.0	HUMAN	Nucleolin
[26]		P31947	1433S_HUMAN	SFN	2	22.2	10.89	1.5e-19	844.9033	4	-0.28	TTFDEAMADLHTLSEDSYKDSTLIMQLLR	TTFDEAM(Oxidation)ADLHTLSEDSYKDSTLIM(Oxidation)QLLR	Oxidation@202;Oxidation@220	29	V20130429-06_FTMSms2hcd	73.015	196	224	46.9	1.5e-19	1.5e-22	1	27774.3	HUMAN	14-3-3 protein sigma
[26]		P31947	1433S_HUMAN	SFN	2	22.2	10.89	1.5e-19	945.1644	3	0.56	LGLALNFSVFHYEIANSPEEAISLAK	LGLALNFSVFHYEIANSPEEAISLAK		26	V20130429-06_FTMSms2hcd	70.262	170	195	41.6	1.5e-9	2.9e-12	1	27774.3	HUMAN	14-3-3 protein sigma
[27]		Q15417	CNN3_HUMAN	CNN3	3	16.1	6.92	3.3e-12	666.7900	2	4.2	CASQAGMTAYGTR	CASQAGM(Oxidation)TAYGTR	Oxidation@179	13	V20130429-06_FTMSms2hcd	10.749	173	185	23.8	3.3e-12	6.0e-15	1	36414.0	HUMAN	Calponin-3
[27]		Q15417	CNN3_HUMAN	CNN3	3	16.1	6.92	3.3e-12	1063.7970	4	14	AIQAYGMKPHDIFEANDLFENGNMTQVQTTLVALAGLAK	AIQAYGM(Oxidation)KPHDIFEANDLFENGNM(Oxidation)TQVQTTLVALAGLAK	Oxidation@98;Oxidation@115	39	V20130429-06_FTMSms2hcd	69.649	92	130	43.6	1.4e-11	3.0e-14	1	36414.0	HUMAN	Calponin-3
[27]		Q15417	CNN3_HUMAN	CNN3	3	16.1	6.92	3.3e-12	776.8279	2	5.7	CASQAGMTAYGTRR	CAS(Phospho)QAGMTAYGTRR	Phospho@175=16	14	V20130429-06_FTMSms2hcd	10.464	173	186	18.2	6.4e-4	1.1e-6	1	36414.0	HUMAN	Calponin-3
[28]		Q15365	PCBP1_HUMAN	PCBP1	2	14.6	8.44	5.1e-15	1089.1022	2	2.1	QVTITGSAASISLAQYLINAR	QVTITGSAASISLAQYLINAR		21	V20130429-06_FTMSms2hcd	63.937	326	346	47.5	5.1e-15	1.7e-17	1	37498.2	HUMAN	Poly(rC)-binding protein 1
[28]		Q15365	PCBP1_HUMAN	PCBP1	2	14.6	8.44	5.1e-15	849.4308	4	0.96	AFAMIIDKLEEDINSSMTNSTAASRPPVTLR	AFAMIIDKLEEDINSSM(Oxidation)TNSTAASRPPVTLR	Oxidation@87=109	31	V20130429-06_FTMSms2hcd	62.847	71	101	45.1	7.0e-13	9.2e-16	1	37498.2	HUMAN	Poly(rC)-binding protein 1
[29]		P09211	GSTP1_HUMAN	GSTP1	2	24.8	8.18	1.5e-14	955.8043	3	1.7	TLGLYGKDQQEAALVDMVNDGVEDLR	TLGLYGKDQQEAALVDM(Oxidation)VNDGVEDLR	Oxidation@92	26	V20130429-06_FTMSms2hcd	53.334	76	101	51.1	1.5e-14	1.5e-17	1	23356.0	HUMAN	Glutathione S-transferase P
[29]		P09211	GSTP1_HUMAN	GSTP1	2	24.8	8.18	1.5e-14	1003.1697	3	7.6	MLLADQGQSWKEEVVTVETWQEGSLK	M(Oxidation)LLADQGQSWKEEVVTVETWQEGSLK	Oxidation@20	26	V20130429-06_FTMSms2hcd	57.506	20	45	44.9	1.0e-12	1.2e-15	1	23356.0	HUMAN	Glutathione S-transferase P
[30]		P00505	AATM_HUMAN	GOT2	2	11.4	8.61	2.5e-15	972.4432	3	2.0	NLFAFFDMAYQGFASGDGDKDAWAVR	NLFAFFDM(Oxidation)AYQGFASGDGDKDAWAVR	Oxidation@244	26	V20130429-06_FTMSms2hcd	75.001	237	262	45.0	2.5e-15	2.3e-18	1	47518.1	HUMAN	Aspartate aminotransferase, mitochondrial
[30]		P00505	AATM_HUMAN	GOT2	2	11.4	8.61	2.5e-15	588.8220	4	-0.36	ISVAGVTSSNVGYLAHAIHQVTK	ISVAGVTSSNVGYLAHAIHQVTK		23	V20130429-06_FTMSms2hcd	54.545	408	430	34.4	1.8e-9	4.6e-12	1	47518.1	HUMAN	Aspartate aminotransferase, mitochondrial
[31]		P25705	ATPA_HUMAN	ATP5A1	3	7.4	6.21	6.7e-11	812.9488	2	-0.085	TGAIVDVPVGEELLGR	TGAIVDVPVGEELLGR		16	V20130429-06_FTMSms2hcd	54.062	134	149	43.6	6.7e-11	1.6e-13	1	59751.1	HUMAN	ATP synthase subunit alpha, mitochondrial
[31]		P25705	ATPA_HUMAN	ATP5A1	3	7.4	6.21	6.7e-11	720.3386	2	1.2	TGTAEMSSILEER	TGTAEM(Oxidation)SSILEER	Oxidation@51	13	V20130429-06_FTMSms2hcd	26.126	46	58	41.3	1.1e-10	1.4e-13	1	59751.1	HUMAN	ATP synthase subunit alpha, mitochondrial
[31]		P25705	ATPA_HUMAN	ATP5A1	3	7.4	6.21	6.7e-11	698.8516	2	-8.9	TSIAIDTIINQK	TSIAIDT(Phospho)IINQK	Phospho@225=41	12	V20130429-06_FTMSms2hcd	15.888	219	230	11.7	0.049	5.7e-5	1	59751.1	HUMAN	ATP synthase subunit alpha, mitochondrial
[32]		P07237	PDIA1_HUMAN	P4HB	2	7.5	7.10	3.1e-13	1256.3100	3	16	TGPAATTLPDGAAAESLVESSEVAVIGFFKDVESDSAK	TGPAATTLPDGAAAESLVESSEVAVIGFFKDVESDSAK		38	V20130429-06_FTMSms2hcd	77.702	133	170	36.2	3.1e-13	6.2e-16	1	57116.8	HUMAN	Protein disulfide-isomerase
[32]		P07237	PDIA1_HUMAN	P4HB	2	7.5	7.10	3.1e-13	979.1820	3	13	TGPAATTLPDGAAAESLVESSEVAVIGFFK	TGPAATTLPDGAAAESLVESSEVAVIGFFK		30	V20130429-06_FTMSms2hcd	77.516	133	162	34.3	3.1e-11	6.6e-14	1	57116.8	HUMAN	Protein disulfide-isomerase
[33]		P35232	PHB_HUMAN	PHB	2	10.7	8.49	4.0e-15	781.6626	4	1.2	AATFGLILDDVSLTHLTFGKEFTEAVEAK	AATFGLILDDVSLTHLTFGKEFTEAVEAK		29	V20130429-06_FTMSms2hcd	73.243	158	186	56.1	4.0e-15	8.0e-18	1	29804.3	HUMAN	Prohibitin
[33]		P35232	PHB_HUMAN	PHB	2	10.7	8.49	4.0e-15	707.0546	3	2.8	AATFGLILDDVSLTHLTFGK	AATFGLILDDVSLTHLTFGK		20	V20130429-06_FTMSms2hcd	70.552	158	177	17.8	2.0e-7	5.0e-10	1	29804.3	HUMAN	Prohibitin
[34]		Q01518	CAP1_HUMAN	CAP1	2	4.6	6.32	4.2e-11	758.1044	3	8.3	LGLVFDDVVGIVEIINSKDVK	LGLVFDDVVGIVEIINSKDVK		21	V20130429-06_FTMSms2hcd	77.368	378	398	35.5	4.2e-11	3.4e-13	1	51901.9	HUMAN	Adenylyl cyclase-associated protein 1
[34]		Q01518	CAP1_HUMAN	CAP1	2	4.6	6.32	4.2e-11	800.7983	3	2.3	KLGLVFDDVVGIVEIINSKDVK	KLGLVFDDVVGIVEIINSKDVK		22	V20130429-06_FTMSms2hcd	75.814	377	398	42.8	2.6e-10	2.9e-12	1	51901.9	HUMAN	Adenylyl cyclase-associated protein 1
[35]		P61978	HNRPK_HUMAN	HNRNPK	2	9.3	6.88	3.9e-12	615.0311	3	0.049	ILSISADIETIGEILKK	ILSISADIETIGEILKK		17	V20130429-06_FTMSms2hcd	71.184	87	103	40.1	3.9e-12	4.4e-14	1	50976.7	HUMAN	Heterogeneous nuclear ribonucleoprotein K
[35]		P61978	HNRPK_HUMAN	HNRNPK	2	9.3	6.88	3.9e-12	1082.7737	3	-0.80	AQPYDPNFYDETYDYGGFTMMFDDRR	AQPYDPNFYDETYDYGGFTM(Oxidation)M(Oxidation)FDDRR	Oxidation@241;Oxidation@242	26	V20130429-06_FTMSms2hcd	53.050	222	247	25.1	6.7e-8	1.4e-10	1	50976.7	HUMAN	Heterogeneous nuclear ribonucleoprotein K
[36]		P31949	S10AB_HUMAN	S100A11	2	15.2	5.59	9.6e-10	925.4574	2	1.9	TEFLSFMNTELAAFTK	TEFLSFMNTELAAFTK		16	V20130429-06_FTMSms2hcd	73.149	37	52	38.0	9.6e-10	9.9e-13	1	11740.6	HUMAN	Protein S100-A11
[36]		P31949	S10AB_HUMAN	S100A11	2	15.2	5.59	9.6e-10	933.4554	2	2.4	TEFLSFMNTELAAFTK	TEFLSFM(Oxidation)NTELAAFTK	Oxidation@43	16	V20130429-06_FTMSms2hcd	60.339	37	52	44.0	1.1e-9	1.2e-12	1	11740.6	HUMAN	Protein S100-A11
[37]		P62158	CALM_HUMAN	CALM1	1	20.8	10.89	1.5e-19	1130.5481	3	0.78	MADQLTEEQIAEFKEAFSLFDKDGDGTITTK	M(Met-loss+Acetyl)ADQLTEEQIAEFKEAFSLFDKDGDGTITTK	Met-loss+Acetyl@1	31	V20130429-06_FTMSms2hcd	72.870	1	31	60.8	1.5e-19	1.6e-22	1	16837.7	HUMAN	Calmodulin
[38]		Q96RT1	LAP2_HUMAN	ERBB2IP	2	4.3	8.72	1.5e-15	1033.1721	3	1.3	SKSATLLYDQPLQVFTGSSSSSDLISGTK	SKS(Phospho)ATLLYDQPLQVFTGSSSSSDLISGTK	Phospho@913|915|917	29	V20130429-06_FTMSms2hcd	60.766	913	941	43.6	1.5e-15	1.6e-18	1	158299.4	HUMAN	Protein LAP2
[38]		Q96RT1	LAP2_HUMAN	ERBB2IP	2	4.3	8.72	1.5e-15	693.1124	5	-18	QSSVSSTASVNLGDPGSTRRAQIPEGDYLSYR	Q(Gln->pyro-Glu)SSVSST(Phospho)ASVNLGDPGSTRRAQIPEGDYLSYR	Gln->pyro-Glu@1077;Phospho@1078|1079|1081|1082|1083|1085|1093|1094	32	V20130429-06_FTMSms2hcd	32.566	1077	1108	11.2	0.0030	3.2e-6	1	158299.4	HUMAN	Protein LAP2
[39]		P00558	PGK1_HUMAN	PGK1	2	7.2	7.94	4.3e-14	843.6925	4	2.1	VADKIQLINNMLDKVNEMIIGGGMAFTFLK	VADKIQLINNM(Oxidation)LDKVNEM(Oxidation)IIGGGM(Oxidation)AFTFLK	Oxidation@227;Oxidation@234;Oxidation@240	30	V20130429-06_FTMSms2hcd	64.044	217	246	46.5	4.3e-14	9.2e-17	1	44615.1	HUMAN	Phosphoglycerate kinase 1
[39]		P00558	PGK1_HUMAN	PGK1	2	7.2	7.94	4.3e-14	839.6923	4	0.33	VADKIQLINNMLDKVNEMIIGGGMAFTFLK	VADKIQLINNM(Oxidation)LDKVNEM(Oxidation)IIGGGMAFTFLK	Oxidation@227=16;Oxidation@234=14	30	V20130429-06_FTMSms2hcd	69.606	217	246	15.9	1.6e-4	3.7e-7	1	44615.1	HUMAN	Phosphoglycerate kinase 1
[40]		P35579	MYH9_HUMAN	MYH9	2	2.0	5.14	3.1e-10	795.0045	3	2.4	KGAGDGSDEEVDGKADGAEAKPAE	KGAGDGS(Phospho)DEEVDGKADGAEAKPAE	Phospho@1943	24	V20130429-06_FTMSms2hcd	15.664	1937	1960	24.3	3.1e-10	3.7e-13	1	226534.2	HUMAN	Myosin-9
[40]		P35579	MYH9_HUMAN	MYH9	2	2.0	5.14	3.1e-10	539.0021	3	-1.5	VISGVLQLGNIVFKK	VISGVLQLGNIVFKK		15	V20130429-06_FTMSms2hcd	57.950	342	356	32.8	5.3e-10	1.4e-11	1	226534.2	HUMAN	Myosin-9
[41]		P55084	ECHB_HUMAN	HADHB	2	4.4	5.17	1.3e-9	618.0086	3	0.54	EVVDYIIFGTVIQEVK	EVVDYIIFGTVIQEVK		16	V20130429-06_FTMSms2hcd	67.777	96	111	36.5	1.3e-9	3.2e-12	1	51294.9	HUMAN	Trifunctional enzyme subunit beta, mitochondrial
[41]		P55084	ECHB_HUMAN	HADHB	2	4.4	5.17	1.3e-9	788.7752	3	2.1	TSVPKEVVDYIIFGTVIQEVK	TSVPKEVVDYIIFGTVIQEVK		21	V20130429-06_FTMSms2hcd	70.275	91	111	36.1	3.5e-9	1.5e-11	1	51294.9	HUMAN	Trifunctional enzyme subunit beta, mitochondrial
[42]		P78371	TCPB_HUMAN	CCT2	2	8.2	5.95	9.7e-12	759.4502	2	-0.42	LTSFIGAIAIGDLVK	LTSFIGAIAIGDLVK		15	V20130429-06_FTMSms2hcd	67.643	26	40	32.8	9.7e-12	7.3e-14	1	57488.7	HUMAN	T-complex protein 1 subunit beta
[42]		P78371	TCPB_HUMAN	CCT2	2	8.2	5.95	9.7e-12	1070.5275	3	-1.4	QLIYNYPEQLFGAAGVMAIEHADFAGVER	QLIYNYPEQLFGAAGVMAIEHADFAGVER		29	V20130429-06_FTMSms2hcd	73.188	294	322	26.9	4.2e-8	4.8e-11	1	57488.7	HUMAN	T-complex protein 1 subunit beta
[43]		P09429	HMGB1_HUMAN	HMGB1	2	13.0	5.77	2.2e-11	728.3227	2	-0.97	MSSYAFFVQTCR	M(Oxidation)SSYAFFVQTCR	Oxidation@13	12	V20130429-06_FTMSms2hcd	44.581	13	24	33.0	2.2e-11	3.3e-14	3	24894.0	HUMAN	High mobility group protein B1
[43]		P09429	HMGB1_HUMAN	HMGB1	2	13.0	5.77	2.2e-11	649.0027	3	7.5	RPPSAFFLFCSEYRPK	RPPSAFFLFCSEYRPK		16	V20130429-06_FTMSms2hcd	52.930	97	112	23.5	7.2e-8	9.9e-11	1	24894.0	HUMAN	High mobility group protein B1
[43-1]	0	P26583	HMGB2_HUMAN	HMGB2	1	5.7	5.77	2.2e-11	728.3227	2	-0.97	MSSYAFFVQTCR	M(Oxidation)SSYAFFVQTCR	Oxidation@13	12	V20130429-06_FTMSms2hcd	44.581	13	24	33.0	2.2e-11	3.3e-14	3	24034.0	HUMAN	High mobility group protein B2
[43-2]	0	B2RPK0	HGB1A_HUMAN	HMGB1P1	1	5.7	5.77	2.2e-11	728.3227	2	-0.97	MSSYAFFVQTCR	M(Oxidation)SSYAFFVQTCR	Oxidation@13	12	V20130429-06_FTMSms2hcd	44.581	13	24	33.0	2.2e-11	3.3e-14	3	24238.2	HUMAN	Putative high mobility group protein B1-like 1
[44]		P06732	KCRM_HUMAN	CKM	2	11.8	6.90	3.6e-12	1254.6411	3	6.9	GTGGVDTAAVGSVFDVSNADRLGSSEVEQVQLVVDGVK	GTGGVDTAAVGSVFDVSNADRLGSSEVEQVQLVVDGVK		38	V20130429-06_FTMSms2hcd	67.072	321	358	40.8	3.6e-12	6.4e-15	1	43101.5	HUMAN	Creatine kinase M-type
[44]		P06732	KCRM_HUMAN	CKM	2	11.8	6.90	3.6e-12	454.2482	2	0.84	FEEILTR	FEEILTR		7	V20130429-06_FTMSms2hcd	30.061	308	314	22.9	4.4e-4	8.7e-7	1	43101.5	HUMAN	Creatine kinase M-type
[45]		P21796	VDAC1_HUMAN	VDAC1	1	7.8	9.34	1.1e-16	1217.5952	2	3.4	GALVLGYEGWLAGYQMNFETAK	GALVLGYEGWLAGYQM(Oxidation)NFETAK	Oxidation@155	22	V20130429-06_FTMSms2hcd	64.458	140	161	47.9	1.1e-16	1.1e-19	1	30772.8	HUMAN	Voltage-dependent anion-selective channel protein 1
[46]		P52272	HNRPM_HUMAN	HNRNPM	1	4.5	9.32	1.2e-16	924.7202	4	0.80	GIGTVTFEQSIEAVQAISMFNGQLLFDRPMHVK	GIGTVTFEQSIEAVQAISM(Oxidation)FNGQLLFDRPM(Oxidation)HVK	Oxidation@263;Oxidation@274	33	V20130429-06_FTMSms2hcd	76.111	245	277	51.9	1.2e-16	1.9e-19	1	77516.4	HUMAN	Heterogeneous nuclear ribonucleoprotein M
[47]		Q16658	FSCN1_HUMAN	FSCN1	1	4.9	8.24	1.2e-14	873.4473	3	1.2	VGKDELFALEQSCAQVVLQAANER	VGKDELFALEQSCAQVVLQAANER		24	V20130429-06_FTMSms2hcd	73.256	248	271	52.2	1.2e-14	1.6e-17	1	54530.4	HUMAN	Fascin
[48]		P27797	CALR_HUMAN	CALR	1	7.0	8.20	1.4e-14	1090.1718	3	1.6	SGTIFDNFLITNDEAYAEEFGNETWGVTK	SGTIFDNFLITNDEAYAEEFGNETWGVTK		29	V20130429-06_FTMSms2hcd	73.834	323	351	45.2	1.4e-14	1.4e-17	1	48141.9	HUMAN	Calreticulin
[49]		P05141	ADT2_HUMAN	SLC25A5	2	6.0	4.69	1.1e-10	585.9833	3	0.21	GMGGAFVLVLYDEIKK	GM(Oxidation)GGAFVLVLYDEIKK	Oxidation@282	16	V20130429-06_FTMSms2hcd	59.800	281	296	26.0	1.1e-10	2.2e-13	3	32852.5	HUMAN	ADP/ATP translocase 2
[49]		P05141	ADT2_HUMAN	SLC25A5	2	6.0	4.69	1.1e-10	674.0205	3	0.48	GMGGAFVLVLYDEIKKYT	GM(Oxidation)GGAFVLVLYDEIKKYT	Oxidation@282	18	V20130429-06_FTMSms2hcd	75.275	281	298	25.4	1.9e-8	2.7e-11	1	32852.5	HUMAN	ADP/ATP translocase 2
[49-1]	0	P12235	ADT1_HUMAN	SLC25A4	1	5.4	4.69	1.1e-10	585.9833	3	0.21	GMGGAFVLVLYDEIKK	GM(Oxidation)GGAFVLVLYDEIKK	Oxidation@282	16	V20130429-06_FTMSms2hcd	59.800	281	296	26.0	1.1e-10	2.2e-13	3	33064.8	HUMAN	ADP/ATP translocase 1
[49-2]	0	P12236	ADT3_HUMAN	SLC25A6	1	5.4	4.69	1.1e-10	585.9833	3	0.21	GMGGAFVLVLYDELKK	GM(Oxidation)GGAFVLVLYDELKK	Oxidation@282	16	V20130429-06_FTMSms2hcd	59.800	281	296	26.0	1.1e-10	2.2e-13	3	32866.6	HUMAN	ADP/ATP translocase 3
[50]		Q99497	PARK7_HUMAN	PARK7	1	13.8	8.04	2.8e-14	882.8236	3	16	GPGTSFEFALAIVEALNGKEVAAQVK	GPGTSFEFALAIVEALNGKEVAAQVK		26	V20130429-06_FTMSms2hcd	77.038	157	182	44.2	2.8e-14	1.2e-16	1	19891.2	HUMAN	Protein DJ-1
[51]		P14406	CX7A2_HUMAN	COX7A2	1	28.9	7.95	4.1e-14	835.1144	3	5.3	ATMILTVGGTAYAIYELAVASFPK	ATM(Oxidation)ILTVGGTAYAIYELAVASFPK	Oxidation@59	24	V20130429-06_FTMSms2hcd	77.754	57	80	41.1	4.1e-14	9.7e-17	1	9396.1	HUMAN	Cytochrome c oxidase subunit 7A2, mitochondrial
[52]		Q99832	TCPH_HUMAN	CCT7	2	9.0	5.14	7.6e-11	723.6179	4	1.2	VHTVEDYQAIVDAEWNILYDKLEK	VHTVEDYQAIVDAEWNILYDKLEK		24	V20130429-06_FTMSms2hcd	68.885	257	280	29.6	7.6e-11	9.7e-14	1	59367.2	HUMAN	T-complex protein 1 subunit eta
[52]		Q99832	TCPH_HUMAN	CCT7	2	9.0	5.14	7.6e-11	867.1416	3	13	INALTAASEAACLIVSVDETIKNPR	INALTAASEAACLIVSVDETIKNPR		25	V20130429-06_FTMSms2hcd	77.274	500	524	21.9	2.6e-6	9.2e-9	1	59367.2	HUMAN	T-complex protein 1 subunit eta
[53]		Q71DI3	H32_HUMAN	HIST2H3A	2	30.1	5.04	8.3e-11	1158.2300	3	-0.25	FQSSAVMALQEASEAYLVGLFEDTNLCAIHAK	FQSSAVM(Oxidation)ALQEASEAYLVGLFEDTNLCAIHAK	Oxidation@91	32	V20130429-06_FTMSms2hcd	77.609	85	116	28.0	8.3e-11	9.2e-14	1	15388.2	HUMAN	Histone H3.2
[53]		Q71DI3	H32_HUMAN	HIST2H3A	2	30.1	5.04	8.3e-11	516.8016	2	1.0	YRPGTVALR	YRPGTVALR		9	V20130429-06_FTMSms2hcd	20.262	42	50	28.8	2.3e-6	6.3e-9	5	15388.2	HUMAN	Histone H3.2
[53-1]	0	P68431	H31_HUMAN	HIST1H3A	1	6.6	2.65	2.3e-6	516.8016	2	1.0	YRPGTVALR	YRPGTVALR		9	V20130429-06_FTMSms2hcd	20.262	42	50	28.8	2.3e-6	6.3e-9	5	15404.2	HUMAN	Histone H3.1
[53-2]	0	P84243	H33_HUMAN	H3F3A	1	6.6	2.65	2.3e-6	516.8016	2	1.0	YRPGTVALR	YRPGTVALR		9	V20130429-06_FTMSms2hcd	20.262	42	50	28.8	2.3e-6	6.3e-9	5	15328.0	HUMAN	Histone H3.3
[53-3]	0	Q16695	H31T_HUMAN	HIST3H3	1	6.6	2.65	2.3e-6	516.8016	2	1.0	YRPGTVALR	YRPGTVALR		9	V20130429-06_FTMSms2hcd	20.262	42	50	28.8	2.3e-6	6.3e-9	5	15508.4	HUMAN	Histone H3.1t
[53-4]	0	Q6NXT2	H3C_HUMAN	H3F3C	1	6.7	2.65	2.3e-6	516.8016	2	1.0	YRPGTVALR	YRPGTVALR		9	V20130429-06_FTMSms2hcd	20.262	41	49	28.8	2.3e-6	6.3e-9	5	15213.9	HUMAN	Histone H3.3C
[54]		P11940	PABP1_HUMAN	PABPC1	1	3.8	7.69	1.2e-13	924.8090	3	12	ITGMLLEIDNSELLHMLESPESLR	ITGM(Oxidation)LLEIDNSELLHM(Oxidation)LESPESLR	Oxidation@584;Oxidation@596	24	V20130429-06_FTMSms2hcd	63.601	581	604	50.9	1.2e-13	1.9e-16	2	70671.5	HUMAN	Polyadenylate-binding protein 1
[54-1]	0	Q13310	PABP4_HUMAN	PABPC4	1	3.7	7.69	1.2e-13	924.8090	3	12	ITGMLLEIDNSELLHMLESPESLR	ITGM(Oxidation)LLEIDNSELLHM(Oxidation)LESPESLR	Oxidation@593;Oxidation@605	24	V20130429-06_FTMSms2hcd	63.601	590	613	50.9	1.2e-13	1.9e-16	2	70783.5	HUMAN	Polyadenylate-binding protein 4
[55]		Q09028	RBBP4_HUMAN	RBBP4	1	7.3	7.46	3.3e-13	860.4300	4	0.50	TIFTGHTAVVEDVSWHLLHESLFGSVADDQK	TIFTGHTAVVEDVSWHLLHESLFGSVADDQK		31	V20130429-06_FTMSms2hcd	67.669	221	251	45.3	3.3e-13	4.0e-16	1	47656.1	HUMAN	Histone-binding protein RBBP4
[56]		Q9P258	RCC2_HUMAN	RCC2	1	4.2	7.37	2.0e-13	804.0756	3	2.1	TLDGIFSEQVAMGYSHSLVIAR	TLDGIFSEQVAM(Oxidation)GYSHSLVIAR	Oxidation@491	22	V20130429-06_FTMSms2hcd	55.408	480	501	38.0	2.0e-13	2.5e-16	1	56085.0	HUMAN	Protein RCC2
[57]		Q7KZF4	SND1_HUMAN	SND1	1	3.4	6.99	2.5e-12	890.6896	4	-3.2	SASYKPVFVTEITDDLHFYVQDVETGTQLEK	SASYKPVFVTEITDDLHFYVQDVETGTQLEK		31	V20130429-06_FTMSms2hcd	72.050	679	709	42.6	2.5e-12	3.1e-15	1	101997.8	HUMAN	Staphylococcal nuclease domain-containing protein 1
[58]		Q9Y3B8	ORN_HUMAN	REXO2	1	8.9	6.87	4.0e-12	820.4344	3	2.8	AVKESTITLQQAEYEFLSFVR	AVKESTITLQQAEYEFLSFVR		21	V20130429-06_FTMSms2hcd	72.520	109	129	46.5	4.0e-12	7.5e-15	1	26833.0	HUMAN	Oligoribonuclease, mitochondrial
[59]		P26599	PTBP1_HUMAN	PTBP1	1	3.4	6.86	1.8e-12	1020.0608	2	9.0	VTPQSLFILFGVYGDVQR	VTPQSLFILFGVYGDVQR		18	V20130429-06_FTMSms2hcd	74.962	349	366	38.0	1.8e-12	5.1e-15	1	57221.8	HUMAN	Polypyrimidine tract-binding protein 1
[60]		P10768	ESTD_HUMAN	ESD	1	7.4	6.83	4.9e-12	863.7543	3	2.9	LQEGYDHSYYFIATFITDHIR	LQEGYDHSYYFIATFITDHIR		21	V20130429-06_FTMSms2hcd	67.764	254	274	44.7	4.9e-12	5.1e-15	1	31463.1	HUMAN	S-formylglutathione hydrolase
[61]		O60814	H2B1K_HUMAN	HIST1H2BK	1	11.9	6.79	6.6e-13	888.4080	2	-0.22	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-06_FTMSms2hcd	55.128	59	73	34.9	6.6e-13	6.9e-16	14	13890.3	HUMAN	Histone H2B type 1-K
[61-1]	0	P06899	H2B1J_HUMAN	HIST1H2BJ	1	11.9	6.79	6.6e-13	888.4080	2	-0.22	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-06_FTMSms2hcd	55.128	59	73	34.9	6.6e-13	6.9e-16	14	13904.3	HUMAN	Histone H2B type 1-J
[61-2]	0	P23527	H2B1O_HUMAN	HIST1H2BO	1	11.9	6.79	6.6e-13	888.4080	2	-0.22	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-06_FTMSms2hcd	55.128	59	73	34.9	6.6e-13	6.9e-16	14	13906.3	HUMAN	Histone H2B type 1-O
[61-3]	0	P33778	H2B1B_HUMAN	HIST1H2BB	1	11.9	6.79	6.6e-13	888.4080	2	-0.22	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-06_FTMSms2hcd	55.128	59	73	34.9	6.6e-13	6.9e-16	14	13950.3	HUMAN	Histone H2B type 1-B
[61-4]	0	P57053	H2BFS_HUMAN	H2BFS	1	11.9	6.79	6.6e-13	888.4080	2	-0.22	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-06_FTMSms2hcd	55.128	59	73	34.9	6.6e-13	6.9e-16	14	13944.3	HUMAN	Histone H2B type F-S
[61-5]	0	P58876	H2B1D_HUMAN	HIST1H2BD	1	11.9	6.79	6.6e-13	888.4080	2	-0.22	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-06_FTMSms2hcd	55.128	59	73	34.9	6.6e-13	6.9e-16	14	13936.3	HUMAN	Histone H2B type 1-D
[61-6]	0	P62807	H2B1C_HUMAN	HIST1H2BC	1	11.9	6.79	6.6e-13	888.4080	2	-0.22	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-06_FTMSms2hcd	55.128	59	73	34.9	6.6e-13	6.9e-16	14	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[61-7]	0	Q16778	H2B2E_HUMAN	HIST2H2BE	1	11.9	6.79	6.6e-13	888.4080	2	-0.22	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-06_FTMSms2hcd	55.128	59	73	34.9	6.6e-13	6.9e-16	14	13920.3	HUMAN	Histone H2B type 2-E
[61-8]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	1	11.9	6.79	6.6e-13	888.4080	2	-0.22	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-06_FTMSms2hcd	55.128	59	73	34.9	6.6e-13	6.9e-16	14	13920.3	HUMAN	Histone H2B type 2-F
[61-9]	0	Q8N257	H2B3B_HUMAN	HIST3H2BB	1	11.9	6.79	6.6e-13	888.4080	2	-0.22	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-06_FTMSms2hcd	55.128	59	73	34.9	6.6e-13	6.9e-16	14	13908.2	HUMAN	Histone H2B type 3-B
[61-10]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	1	11.9	6.79	6.6e-13	888.4080	2	-0.22	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-06_FTMSms2hcd	55.128	59	73	34.9	6.6e-13	6.9e-16	14	13892.2	HUMAN	Histone H2B type 1-H
[61-11]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	1	11.9	6.79	6.6e-13	888.4080	2	-0.22	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-06_FTMSms2hcd	55.128	59	73	34.9	6.6e-13	6.9e-16	14	13922.3	HUMAN	Histone H2B type 1-N
[61-12]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	1	11.9	6.79	6.6e-13	888.4080	2	-0.22	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-06_FTMSms2hcd	55.128	59	73	34.9	6.6e-13	6.9e-16	14	13989.4	HUMAN	Histone H2B type 1-M
[61-13]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	1	11.9	6.79	6.6e-13	888.4080	2	-0.22	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-06_FTMSms2hcd	55.128	59	73	34.9	6.6e-13	6.9e-16	14	13952.3	HUMAN	Histone H2B type 1-L
[62]		Q00839	HNRPU_HUMAN	HNRNPU	1	3.3	6.64	1.5e-12	1044.1686	3	-0.41	GNFTLPEVAECFDEITYVELQKEEAQK	GNFTLPEVAECFDEITYVELQKEEAQK		27	V20130429-06_FTMSms2hcd	74.368	638	664	35.3	1.5e-12	1.5e-15	1	90585.2	HUMAN	Heterogeneous nuclear ribonucleoprotein U
[63]		P06748	NPM_HUMAN	NPM1	1	11.9	6.30	1.4e-11	918.7313	4	-4.5	TVSLGAGAKDELHIVEAEAMNYEGSPIKVTLATLK	TVSLGAGAKDELHIVEAEAM(Oxidation)NYEGSPIKVTLATLK	Oxidation@65	35	V20130429-06_FTMSms2hcd	62.632	46	80	37.2	1.4e-11	3.6e-14	1	32575.3	HUMAN	Nucleophosmin
[64]		Q9UQ80	PA2G4_HUMAN	PA2G4	2	10.2	3.91	1.3e-9	919.3843	2	2.4	TAENATSGETLEENEAGD	TAENATSGETLEENEAGD		18	V20130429-06_FTMSms2hcd	23.036	377	394	23.9	1.3e-9	1.8e-12	1	43787.3	HUMAN	Proliferation-associated protein 2G4
[64]		Q9UQ80	PA2G4_HUMAN	PA2G4	2	10.2	3.91	1.3e-9	889.1317	3	5.4	HELLQPFNVLYEKEGEFVAQFK	HELLQPFNVLYEKEGEFVAQFK		22	V20130429-06_FTMSms2hcd	65.641	299	320	19.6	1.5e-6	2.7e-9	1	43787.3	HUMAN	Proliferation-associated protein 2G4
[65]		P0CG47	UBB_HUMAN	UBB	1	7.0	6.09	4.7e-11	894.4688	2	1.7	TITLEVEPSDTIENVK	TITLEVEPSDTIENVK		16	V20130429-06_FTMSms2hcd	44.542	12	27	38.0	4.7e-11	6.6e-14	4	25761.8	HUMAN	Polyubiquitin-B
[65-1]	0	P0CG48	UBC_HUMAN	UBC	1	2.3	6.09	4.7e-11	894.4688	2	1.7	TITLEVEPSDTIENVK	TITLEVEPSDTIENVK		16	V20130429-06_FTMSms2hcd	44.542	12	27	38.0	4.7e-11	6.6e-14	4	77029.2	HUMAN	Polyubiquitin-C
[65-2]	0	P62979	RS27A_HUMAN	RPS27A	1	10.3	6.09	4.7e-11	894.4688	2	1.7	TITLEVEPSDTIENVK	TITLEVEPSDTIENVK		16	V20130429-06_FTMSms2hcd	44.542	12	27	38.0	4.7e-11	6.6e-14	4	17965.1	HUMAN	Ubiquitin-40S ribosomal protein S27a
[65-3]	0	P62987	RL40_HUMAN	UBA52	1	12.5	6.09	4.7e-11	894.4688	2	1.7	TITLEVEPSDTIENVK	TITLEVEPSDTIENVK		16	V20130429-06_FTMSms2hcd	44.542	12	27	38.0	4.7e-11	6.6e-14	4	14728.5	HUMAN	Ubiquitin-60S ribosomal protein L40
[66]		P37802	TAGL2_HUMAN	TAGLN2	1	9.0	5.85	3.2e-10	1050.5189	2	1.0	YGINTTDIFQTVDLWEGK	YGINTTDIFQTVDLWEGK		18	V20130429-06_FTMSms2hcd	69.169	103	120	46.1	3.2e-10	3.3e-13	1	22391.7	HUMAN	Transgelin-2
[67]		P23246	SFPQ_HUMAN	SFPQ	1	3.3	5.81	1.2e-10	880.4314	3	-7.2	NLSPYVSNELLEEAFSQFGPIER	NLSPYVSNELLEEAFSQFGPIER		23	V20130429-06_FTMSms2hcd	74.841	377	399	37.2	1.2e-10	1.2e-13	1	76150.0	HUMAN	Splicing factor, proline- and glutamine-rich
[68]		Q08211	DHX9_HUMAN	DHX9	1	1.4	5.80	1.5e-10	693.0101	3	0.95	FSDHVALLSVFQAWDDAR	FSDHVALLSVFQAWDDAR		18	V20130429-06_FTMSms2hcd	67.497	912	929	37.8	1.5e-10	1.6e-13	1	140959.7	HUMAN	ATP-dependent RNA helicase A
[69]		P62081	RS7_HUMAN	RPS7	2	11.9	4.29	1.5e-9	631.6010	4	0.18	TLTAVHDAILEDLVFPSEIVGKR	TLTAVHDAILEDLVFPSEIVGKR		23	V20130429-06_FTMSms2hcd	64.985	121	143	28.1	1.5e-9	6.5e-12	1	22127.0	HUMAN	40S ribosomal protein S7
[69]		P62081	RS7_HUMAN	RPS7	2	11.9	4.29	1.5e-9	789.7642	3	-1.1	TLTAVHDAILEDLVFPSEIVGK	TLTAVHDAILEDLVFPSEIVGK		22	V20130429-06_FTMSms2hcd	68.657	121	142	14.6	3.4e-4	8.6e-7	1	22127.0	HUMAN	40S ribosomal protein S7
[70]		P27816	MAP4_HUMAN	MAP4	1	2.8	5.57	4.8e-11	1128.2819	3	3.2	IVPAKDLVLLSEIEVAQANDIISSTEISSAEK	IVPAKDLVLLSEIEVAQANDIISSTEISSAEK		32	V20130429-06_FTMSms2hcd	75.578	404	435	32.8	4.8e-11	2.3e-13	1	121006.0	HUMAN	Microtubule-associated protein 4
[71]		Q14498	RBM39_HUMAN	RBM39	1	3.2	5.56	4.8e-11	915.4072	2	1.9	TDASSASSFLDSDELER	TDASSASSFLDSDELER		17	V20130429-06_FTMSms2hcd	42.048	330	346	32.7	4.8e-11	5.7e-14	1	59380.1	HUMAN	RNA-binding protein 39
[72]		P46778	RL21_HUMAN	RPL21	2	20.6	4.13	2.3e-9	1047.5183	2	9.2	TNGKEPELLEPIPYEFMA	TNGKEPELLEPIPYEFM(Oxidation)A	Oxidation@159	18	V20130429-06_FTMSms2hcd	57.373	143	160	27.4	2.3e-9	2.4e-12	1	18565.0	HUMAN	60S ribosomal protein L21
[72]		P46778	RL21_HUMAN	RPL21	2	20.6	4.13	2.3e-9	547.6430	3	1.6	VYNVTQHAVGIVVNK	VYNVTQHAVGIVVNK		15	V20130429-06_FTMSms2hcd	34.714	64	78	14.1	2.5e-4	7.1e-7	1	18565.0	HUMAN	60S ribosomal protein L21
[73]		P15880	RS2_HUMAN	RPS2	1	3.8	5.21	1.3e-10	693.8511	2	0.67	TYSYLTPDLWK	TYSYLTPDLWK		11	V20130429-06_FTMSms2hcd	51.317	247	257	31.4	1.3e-10	1.8e-13	1	31324.7	HUMAN	40S ribosomal protein S2
[74]		P06753	TPM3_HUMAN	TPM3	1	4.6	5.20	5.1e-9	738.8400	2	-5.8	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-06_FTMSms2hcd	13.347	113	125	51.0	5.1e-9	5.9e-12	4	32819.1	HUMAN	Tropomyosin alpha-3 chain
[74-1]	0	P07951	TPM2_HUMAN	TPM2	1	4.6	5.20	5.1e-9	738.8400	2	-5.8	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-06_FTMSms2hcd	13.347	113	125	51.0	5.1e-9	5.9e-12	4	32851.0	HUMAN	Tropomyosin beta chain
[74-2]	0	P09493	TPM1_HUMAN	TPM1	1	4.6	5.20	5.1e-9	738.8400	2	-5.8	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-06_FTMSms2hcd	13.347	113	125	51.0	5.1e-9	5.9e-12	4	32708.8	HUMAN	Tropomyosin alpha-1 chain
[74-3]	0	P67936	TPM4_HUMAN	TPM4	1	5.2	5.20	5.1e-9	738.8400	2	-5.8	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-06_FTMSms2hcd	13.347	77	89	51.0	5.1e-9	5.9e-12	4	28522.0	HUMAN	Tropomyosin alpha-4 chain
[75]		O95067	CCNB2_HUMAN	CCNB2	1	5.8	5.17	5.7e-9	836.4279	3	7.6	MALLRRPTVSSDLENIDTGVNSK	M(Met-loss+Acetyl)ALLRRPT(Phospho)VSSDLENIDTGVNSK	Met-loss+Acetyl@1;Phospho@8=7	23	V20130429-06_FTMSms2hcd	49.784	1	23	40.8	5.7e-9	7.6e-12	1	45282.0	HUMAN	G2/mitotic-specific cyclin-B2
[76]		Q99729	ROAA_HUMAN	HNRNPAB	1	6.3	5.10	2.7e-10	833.7441	3	2.6	IREYFGEFGEIEAIELPMDPK	IREYFGEFGEIEAIELPM(Oxidation)DPK	Oxidation@187	21	V20130429-06_FTMSms2hcd	58.605	170	190	32.1	2.7e-10	2.7e-13	1	36225.2	HUMAN	Heterogeneous nuclear ribonucleoprotein A/B
[77]		P42025	ACTY_HUMAN	ACTR1B	1	5.1	5.07	5.6e-11	700.7189	3	2.2	LYSTWIGGSILASLDTFKK	LYSTWIGGSILASLDTFKK		19	V20130429-06_FTMSms2hcd	70.409	337	355	28.1	5.6e-11	1.4e-13	2	42293.8	HUMAN	Beta-centractin
[77-1]	0	P61163	ACTZ_HUMAN	ACTR1A	1	5.1	5.07	5.6e-11	700.7189	3	2.2	LYSTWIGGSILASLDTFKK	LYSTWIGGSILASLDTFKK		19	V20130429-06_FTMSms2hcd	70.409	337	355	28.1	5.6e-11	1.4e-13	2	42614.1	HUMAN	Alpha-centractin
[78]		P62847	RS24_HUMAN	RPS24	1	9.0	4.94	3.0e-10	699.8759	2	2.1	TTPDVIFVFGFR	TTPDVIFVFGFR		12	V20130429-06_FTMSms2hcd	65.615	50	61	30.8	3.0e-10	5.7e-13	1	15423.3	HUMAN	40S ribosomal protein S24
[79]		O75531	BAF_HUMAN	BANF1	1	13.5	4.64	6.3e-9	675.4137	2	0.73	AYVVLGQFLVLK	AYVVLGQFLVLK		12	V20130429-06_FTMSms2hcd	64.191	42	53	34.9	6.3e-9	1.1e-10	1	10058.7	HUMAN	Barrier-to-autointegration factor
[80]		P43487	RANG_HUMAN	RANBP1	1	5.5	4.54	1.9e-8	691.3229	2	1.2	TLEEDEEELFK	TLEEDEEELFK		11	V20130429-06_FTMSms2hcd	44.160	40	50	36.5	1.9e-8	2.7e-11	1	23310.3	HUMAN	Ran-specific GTPase-activating protein
[81]		P46777	RL5_HUMAN	RPL5	1	6.1	4.51	3.1e-8	624.0013	3	0.12	VGLTNYAAAYCTGLLLAR	VGLTNYAAAYCTGLLLAR		18	V20130429-06_FTMSms2hcd	67.523	90	107	37.4	3.1e-8	5.5e-11	1	34362.9	HUMAN	60S ribosomal protein L5
[82]		P22314	UBA1_HUMAN	UBA1	1	2.6	4.51	7.2e-9	542.9565	6	1.6	FSRPAQLHIGFQALHQFCAQHGRPPRPR	FSRPAQLHIGFQALHQFCAQHGRPPRPR		28	V20130429-06_FTMSms2hcd	42.901	323	350	33.9	7.2e-9	1.6e-11	1	117850.0	HUMAN	Ubiquitin-like modifier-activating enzyme 1
[83]		P11586	C1TC_HUMAN	MTHFD1	1	1.4	4.18	2.8e-9	752.8555	2	-5.9	TDPTTLTDEEINR	TDPTTLTDEEINR		13	V20130429-06_FTMSms2hcd	29.979	505	517	28.4	2.8e-9	3.4e-12	1	101560.1	HUMAN	C-1-tetrahydrofolate synthase, cytoplasmic
[84]		Q8NC51	PAIRB_HUMAN	SERBP1	1	5.1	4.17	3.0e-10	1052.4907	2	1.2	TDKSSASAPDVDDPEAFPALA	TDKSSASAPDVDDPEAFPALA		21	V20130429-06_FTMSms2hcd	45.836	388	408	23.1	3.0e-10	3.2e-13	1	44965.7	HUMAN	Plasminogen activator inhibitor 1 RNA-binding protein
[85]		O60841	IF2P_HUMAN	EIF5B	1	1.9	4.15	3.6e-8	869.7929	3	2.9	AIIVEFAQQGLNAALFYENKDPR	AIIVEFAQQGLNAALFYENKDPR		23	V20130429-06_FTMSms2hcd	65.722	793	815	34.1	3.6e-8	6.7e-11	1	138828.0	HUMAN	Eukaryotic translation initiation factor 5B
[86]		P61758	PFD3_HUMAN	VBP1	1	12.7	3.96	6.5e-9	996.7974	3	-3.8	NLDSLEEDLDFLRDQFTTTEVNMAR	NLDSLEEDLDFLRDQFTTTEVNM(Oxidation)AR	Oxidation@176	25	V20130429-06_FTMSms2hcd	72.654	154	178	28.2	6.5e-9	6.0e-12	1	22658.2	HUMAN	Prefoldin subunit 3
[87]		P23284	PPIB_HUMAN	PPIB	1	6.0	3.92	2.3e-7	682.8571	2	0.95	TVDNFVALATGEK	TVDNFVALATGEK		13	V20130429-06_FTMSms2hcd	45.423	72	84	36.1	2.3e-7	3.1e-10	1	23742.7	HUMAN	Peptidyl-prolyl cis-trans isomerase B
[88]		P36405	ARL3_HUMAN	ARL3	1	10.4	3.83	1.3e-8	763.7219	3	5.0	NYFENTDILIYVIDSADRK	NYFENTDILIYVIDSADRK		19	V20130429-06_FTMSms2hcd	68.631	80	98	28.5	1.3e-8	1.7e-11	1	20455.7	HUMAN	ADP-ribosylation factor-like protein 3
[89]		Q9Y2W1	TR150_HUMAN	THRAP3	1	1.9	3.80	1.0e-9	511.2849	4	-0.20	SPSELFAQHIVTIVHHVK	SPSELFAQHIVTIVHHVK		18	V20130429-06_FTMSms2hcd	47.695	622	639	22.2	1.0e-9	2.8e-12	1	108666.6	HUMAN	Thyroid hormone receptor-associated protein 3
[90]		P26639	SYTC_HUMAN	TARS	1	1.8	3.43	4.3e-9	771.9216	2	2.9	GAYIYNALIEFIR	GAYIYNALIEFIR		13	V20130429-06_FTMSms2hcd	72.236	349	361	21.9	4.3e-9	8.8e-12	1	83435.8	HUMAN	Threonine--tRNA ligase, cytoplasmic
[91]		O60361	NDK8_HUMAN	NME2P1	1	7.3	3.42	1.6e-8	423.2246	3	1.9	FKPEELVDYK	FKPEELVDYK		10	V20130429-06_FTMSms2hcd	35.652	119	128	24.9	1.6e-8	2.3e-11	1	15529.2	HUMAN	Putative nucleoside diphosphate kinase
[92]		Q14008	CKAP5_HUMAN	CKAP5	1	1.1	3.39	3.1e-9	807.8049	3	4.3	ILVQQTLNILQQLAVAMGPNIK	ILVQQTLNILQQLAVAM(Oxidation)GPNIK	Oxidation@931	22	V20130429-06_FTMSms2hcd	73.886	915	936	20.8	3.1e-9	4.8e-11	1	225496.6	HUMAN	Cytoskeleton-associated protein 5
[93]		Q8N187	AL2S8_HUMAN	ALS2CR8	1	1.0	3.26	1.4e-9	464.2016	2	3.0	VETNQTR	VETNQT(Phospho)R	Phospho@536=44	7	V20130429-06_FTMSms2hcd	14.084	531	537	17.6	1.4e-9	3.4e-12	1	80698.6	HUMAN	Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein
[94]		P15531	NDKA_HUMAN	NME1	1	7.9	3.23	3.8e-8	672.8861	2	1.1	TFIAIKPDGVQR	TFIAIKPDGVQR		12	V20130429-06_FTMSms2hcd	32.110	7	18	25.0	3.8e-8	9.9e-11	2	17148.9	HUMAN	Nucleoside diphosphate kinase A
[94-1]	0	P22392	NDKB_HUMAN	NME2	1	7.9	3.23	3.8e-8	672.8861	2	1.1	TFIAIKPDGVQR	TFIAIKPDGVQR		12	V20130429-06_FTMSms2hcd	32.110	7	18	25.0	3.8e-8	9.9e-11	2	17298.2	HUMAN	Nucleoside diphosphate kinase B
[95]		P07737	PROF1_HUMAN	PFN1	1	5.7	3.14	1.7e-8	445.7722	2	-0.93	TLVLLMGK	TLVLLM(Oxidation)GK	Oxidation@114	8	V20130429-06_FTMSms2hcd	34.954	109	116	22.3	1.7e-8	8.3e-11	1	15054.4	HUMAN	Profilin-1
[96]		P14174	MIF_HUMAN	MIF	1	7.8	3.12	2.5e-5	494.2868	2	0.77	LLCGLLAER	LLCGLLAER		9	V20130429-06_FTMSms2hcd	46.654	79	87	39.1	2.5e-5	4.3e-8	1	12476.4	HUMAN	Macrophage migration inhibitory factor
[97]		O75534	CSDE1_HUMAN	CSDE1	1	2.9	2.96	1.3e-7	858.4567	3	2.3	LLPQGTVIFEDISIEHFEGTVTK	LLPQGTVIFEDISIEHFEGTVTK		23	V20130429-06_FTMSms2hcd	64.588	247	269	25.1	1.3e-7	2.6e-10	1	88885.4	HUMAN	Cold shock domain-containing protein E1
[98]		P04075	ALDOA_HUMAN	ALDOA	1	7.4	2.66	5.5e-8	1013.8749	3	4.3	QLLLTADDRVNPCIGGVILFHETLYQK	Q(Gln->pyro-Glu)LLLTADDRVNPCIGGVILFHETLYQK	Gln->pyro-Glu@61	27	V20130429-06_FTMSms2hcd	72.959	61	87	20.2	5.5e-8	1.5e-10	1	39420.4	HUMAN	Fructose-bisphosphate aldolase A
[99]		Q9NR30	DDX21_HUMAN	DDX21	1	1.4	2.64	7.6e-6	633.3612	2	0.89	TFSFAIPLIEK	TFSFAIPLIEK		11	V20130429-06_FTMSms2hcd	62.189	237	247	31.6	7.6e-6	2.5e-8	1	87345.1	HUMAN	Nucleolar RNA helicase 2
[100]		Q9Y4L1	HYOU1_HUMAN	HYOU1	1	2.8	2.54	8.0e-8	1041.5600	3	3.6	MVEEIGVELVVLDLPDLPEDKLAQSVQK	M(Oxidation)VEEIGVELVVLDLPDLPEDKLAQSVQK	Oxidation@695	28	V20130429-06_FTMSms2hcd	70.807	695	722	19.9	8.0e-8	2.3e-10	1	111336.3	HUMAN	Hypoxia up-regulated protein 1
[101]		Q9HB71	CYBP_HUMAN	CACYBP	1	8.3	2.38	8.5e-7	714.7238	3	1.3	MASEELQKDLEEVKVLLEK	M(Met-loss+Acetyl)ASEELQKDLEEVKVLLEK	Met-loss+Acetyl@1	19	V20130429-06_FTMSms2hcd	72.318	1	19	23.8	8.5e-7	2.0e-9	1	26210.2	HUMAN	Calcyclin-binding protein
[102]		O15460	P4HA2_HUMAN	P4HA2	1	3.6	2.33	2.9e-7	742.0495	3	-2.6	SQVLDYLSYAVFQLGDLHR	SQVLDYLSYAVFQLGDLHR		19	V20130429-06_FTMSms2hcd	74.988	207	225	20.8	2.9e-7	3.7e-10	1	60902.5	HUMAN	Prolyl 4-hydroxylase subunit alpha-2
[103]		Q12882	DPYD_HUMAN	DPYD	2	1.5	1.13	0.0014	928.4117	2	0.073	SLSVNEMTLSTLKEK	SLSVNEM(Oxidation)T(Phospho)LST(Phospho)LKEK	Oxidation@266;Phospho@262&267|262&269|262&270|267&269|267&270|269&270	15	V20130429-06_FTMSms2hcd	28.524	260	274	22.1	0.0014	1.6e-6	1	111402.5	HUMAN	Dihydropyrimidine dehydrogenase [NADP(+)]
[103]		Q12882	DPYD_HUMAN	DPYD	2	1.5	1.13	0.0014	920.4264	2	13	SLSVNEMTLSTLKEK	SLSVNEMT(Phospho)LS(Phospho)TLKEK	Phospho@267&269|267&270|269&270	15	V20130429-06_FTMSms2hcd	28.370	260	274	28.6	0.0015	1.7e-6	1	111402.5	HUMAN	Dihydropyrimidine dehydrogenase [NADP(+)]
[104]		P05387	RLA2_HUMAN	RPLP2	1	18.3	2.12	2.9e-6	724.7128	3	5.6	MRYVASYLLAALGGNSSPSAK	M(Oxidation)RYVASYLLAALGGNSSPSAK	Oxidation@1	21	V20130429-06_FTMSms2hcd	55.154	1	21	24.1	2.9e-6	4.2e-9	1	11665.0	HUMAN	60S acidic ribosomal protein P2
[105]		Q8TEM1	PO210_HUMAN	NUP210	1	0.5	1.99	4.8e-7	511.2878	2	0.64	VPVVHVDEK	VPVVHVDEK		9	V20130429-06_FTMSms2hcd	36.002	1329	1337	18.6	4.8e-7	1.3e-9	1	205112.9	HUMAN	Nuclear pore membrane glycoprotein 210
[106]		P62266	RS23_HUMAN	RPS23	1	18.9	1.95	4.8e-7	980.4919	3	13	ITAFVPNDGCLNFIEENDEVLVAGFGR	ITAFVPNDGCLNFIEENDEVLVAGFGR		27	V20130429-06_FTMSms2hcd	76.068	81	107	18.2	4.8e-7	5.9e-10	1	15807.7	HUMAN	40S ribosomal protein S23
[107]		P13010	XRCC5_HUMAN	XRCC5	1	3.8	1.89	1.6e-6	1023.8613	3	4.3	IQPGSQQADFLDALIVSMDVIQHETIGK	IQPGSQQADFLDALIVSM(Oxidation)DVIQHETIGK	Oxidation@115	28	V20130429-06_FTMSms2hcd	72.546	98	125	20.4	1.6e-6	2.6e-9	1	82705.3	HUMAN	X-ray repair cross-complementing protein 5
[108]		Q9BZ72	PITM2_HUMAN	PITPNM2	1	0.5	1.53	0.0013	435.2582	2	0.034	LEPLLER	LEPLLER		7	V20130429-06_FTMSms2hcd	30.594	769	775	32.4	0.0013	5.5e-6	1	148934.5	HUMAN	Membrane-associated phosphatidylinositol transfer protein 2
[109]		Q05932	FOLC_HUMAN	FPGS	1	2.9	1.46	1.6e-7	1059.9398	2	19	LEETKDGSCVSMPPYFR	LEET(Phospho)KDGSCVSMPPY(Phospho)FR	Phospho@177=58;Phospho@166|170|173	17	V20130429-06_FTMSms2hcd	37.641	163	179	10.7	1.6e-7	2.2e-10	1	64609.7	HUMAN	Folylpolyglutamate synthase, mitochondrial
[110]		Q9Y5Z7	HCFC2_HUMAN	HCFC2	1	2.1	1.29	1.4e-6	620.9520	3	-3.5	TCIPGFPGAPSAVRISK	TCIPGFPGAPS(Phospho)AVRIS(Phospho)K	Phospho@682=59;Phospho@687=69	17	V20130429-06_FTMSms2hcd	38.095	672	688	14.1	1.4e-6	1.6e-9	1	86779.8	HUMAN	Host cell factor 2
[111]		O14503	BHE40_HUMAN	BHLHE40	1	2.9	1.28	5.0e-6	703.3181	2	12	VVSELLQGGTSR	VVS(Phospho)ELLQGGTS(Phospho)R	Phospho@180=67;Phospho@187|188	12	V20130429-06_FTMSms2hcd	57.118	178	189	17.0	5.0e-6	6.6e-9	1	45510.4	HUMAN	Class E basic helix-loop-helix protein 40
[112]		Q9Y3I0	RTCB_HUMAN	C22orf28	1	5.9	1.20	3.6e-5	1073.2100	3	-0.30	GLPQLGTLGAGNHYAEIQVVDEIFNEYAAK	GLPQLGTLGAGNHYAEIQVVDEIFNEYAAK		30	V20130429-06_FTMSms2hcd	71.727	215	244	20.8	3.6e-5	4.5e-8	1	55210.8	HUMAN	tRNA-splicing ligase RtcB homolog
[113]		O95466	FMNL_HUMAN	FMNL1	1	0.9	1.17	2.1e-4	569.2679	2	-1.3	RDSELGPGVK	RDS(Phospho)ELGPGVK	Phospho@624	10	V20130429-06_FTMSms2hcd	16.751	622	631	24.6	2.1e-4	3.8e-7	1	121854.6	HUMAN	Formin-like protein 1
[114]		Q9C0D5	TANC1_HUMAN	TANC1	1	0.9	1.16	4.4e-5	704.9968	3	-7.6	FPREGFGEDMRPFNELR	FPREGFGEDM(Oxidation)RPFNELR	Oxidation@1328	17	V20130429-06_FTMSms2hcd	55.715	1319	1335	20.9	4.4e-5	4.3e-8	1	202221.0	HUMAN	Protein TANC1
[115]		Q4G0P3	HYDIN_HUMAN	HYDIN	1	0.2	1.10	7.9e-5	649.8401	2	4.8	LPPELYEYFK	LPPELYEYFK		10	V20130429-06_FTMSms2hcd	43.834	1898	1907	21.6	7.9e-5	1.2e-7	1	575897.1	HUMAN	Hydrocephalus-inducing protein homolog
[116]		P07195	LDHB_HUMAN	LDHB	1	10.8	1.03	1.7e-5	1197.9928	3	4.2	LIAPVAEEEATVPNNKITVVGVGQVGMACAISILGK	LIAPVAEEEATVPNNKITVVGVGQVGMACAISILGK		36	V20130429-06_FTMSms2hcd	75.604	8	43	17.4	1.7e-5	1.2e-7	1	36638.8	HUMAN	L-lactate dehydrogenase B chain
[117]		O95025	SEM3D_HUMAN	SEMA3D	1	1.5	0.95	2.4e-5	738.3141	2	3.8	IPYPRPGTCPSK	IPY(Phospho)PRPGTCPS(Phospho)K	Phospho@392=8;Phospho@397|400	12	V20130429-06_FTMSms2hcd	16.123	390	401	17.4	2.4e-5	4.0e-8	1	89652.1	HUMAN	Semaphorin-3D
[118]		P52566	GDIR2_HUMAN	ARHGDIB	1	3.5	0.91	2.0e-5	523.7279	2	2.9	YVQHTYR	YVQHT(Phospho)YR	Phospho@129=17	7	V20130429-06_FTMSms2hcd	15.707	125	131	16.6	2.0e-5	4.1e-8	1	22988.2	HUMAN	Rho GDP-dissociation inhibitor 2
[119]		Q4G0M1	F132B_HUMAN	FAM132B	1	4.0	0.87	1.5e-4	750.3648	2	15	AGPAARPPEPTAER	AGPAARPPEPT(Phospho)AER	Phospho@69	14	V20130429-06_FTMSms2hcd	24.611	59	72	20.8	1.5e-4	1.8e-7	1	37279.2	HUMAN	Protein FAM132B
[120]		Q9Y6A5	TACC3_HUMAN	TACC3	1	0.8	0.82	0.0017	433.2241	2	-0.56	EVIEGYR	EVIEGYR		7	V20130429-06_FTMSms2hcd	19.178	734	740	26.1	0.0017	3.4e-6	1	90360.4	HUMAN	Transforming acidic coiled-coil-containing protein 3
[121]		Q6BCY4	NB5R2_HUMAN	CYB5R2	1	2.9	0.77	0.0041	494.2770	2	-0.22	KELEEIAR	KELEEIAR		8	V20130429-06_FTMSms2hcd	43.320	195	202	27.6	0.0041	6.8e-6	1	31458.5	HUMAN	NADH-cytochrome b5 reductase 2
[122]		Q9Y4B5	CC165_HUMAN	CCDC165	1	1.5	0.77	1.1e-4	928.4310	3	7.2	GSGVTSSPHKCLTPKAGGGATPVSSPSR	GSGVTSSPHKCLT(Phospho)PKAGGGATPVS(Phospho)SPSR	Phospho@1658=20;Phospho@1666|1669|1670|1672	28	V20130429-06_FTMSms2hcd	37.746	1646	1673	19.2	1.1e-4	1.1e-7	1	208750.8	HUMAN	Coiled-coil domain-containing protein 165
[123]		Q86UQ4	ABCAD_HUMAN	ABCA13	1	0.1	0.77	0.0011	426.2716	2	1.2	HILDIIK	HILDIIK		7	V20130429-06_FTMSms2hcd	36.271	994	1000	24.4	0.0011	1.5e-5	1	576164.4	HUMAN	ATP-binding cassette sub-family A member 13
[124]		Q14315	FLNC_HUMAN	FLNC	1	0.3	0.68	1.7e-4	433.6875	2	-10	ASGPGLER	AS(Phospho)GPGLER	Phospho@1161	8	V20130429-06_FTMSms2hcd	12.289	1160	1167	19.3	1.7e-4	6.6e-7	1	291024.6	HUMAN	Filamin-C
[125]		Q5VVM6	CCD30_HUMAN	CCDC30	1	1.5	0.63	5.2e-4	695.3227	2	2.0	EGQKEEGSQQNR	EGQKEEGSQQNR		12	V20130429-06_FTMSms2hcd	25.112	166	177	21.4	5.2e-4	6.8e-7	1	91334.1	HUMAN	Coiled-coil domain-containing protein 30
[126]		Q96MH6	TMM68_HUMAN	TMEM68	1	3.7	0.63	0.027	665.3604	2	-4.5	IPGNIMSALLER	IPGNIM(Oxidation)SALLER	Oxidation@316	12	V20130429-06_FTMSms2hcd	19.674	311	322	30.6	0.027	4.4e-5	1	37425.1	HUMAN	Transmembrane protein 68
[127]		Q86UP3	ZFHX4_HUMAN	ZFHX4	1	0.3	0.61	7.9e-5	723.3559	2	-0.28	LQIHSQYHAIR	LQIHSQY(Phospho)HAIR	Phospho@1373=10	11	V20130429-06_FTMSms2hcd	42.793	1367	1377	16.7	7.9e-5	9.7e-8	1	393733.1	HUMAN	Zinc finger homeobox protein 4
[128]		Q0D2J5	ZN763_HUMAN	ZNF763	1	2.8	0.56	1.9e-4	668.3260	2	7.7	ALSYKFSNTPK	ALSYKFS(Phospho)NTPK	Phospho@382|384	11	V20130429-06_FTMSms2hcd	29.794	376	386	18.2	1.9e-4	2.6e-7	1	46099.6	HUMAN	Zinc finger protein 763
[129]		Q14624	ITIH4_HUMAN	ITIH4	2	2.3	0.49	0.0024	501.2903	2	-0.50	LLLRDTDR	LLLRDTDR		8	V20130429-06_FTMSms2hcd	18.858	859	866	23.5	0.0024	4.6e-6	1	103358.3	HUMAN	Inter-alpha-trypsin inhibitor heavy chain H4
[129]		Q14624	ITIH4_HUMAN	ITIH4	2	2.3	0.49	0.0024	697.8860	2	-4.6	LLFKGSEMVVAGK	LLFKGSEM(Oxidation)VVAGK	Oxidation@491	13	V20130429-06_FTMSms2hcd	17.957	484	496	14.9	0.016	3.3e-5	1	103358.3	HUMAN	Inter-alpha-trypsin inhibitor heavy chain H4
[130]		P56181	NDUV3_HUMAN	NDUFV3	1	26.9	0.49	1.9e-4	778.3696	4	-14	AGALKTMLQEAQVFRGLASTVSLSAESGK	AGALKT(Phospho)MLQEAQVFRGLASTVS(Phospho)LSAESGK	Phospho@17&33|17&35|17&38|30&33|30&35|30&38	29	V20130429-06_FTMSms2hcd	58.257	12	40	17.6	1.9e-4	1.9e-7	1	11940.6	HUMAN	NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial
[131]		Q5T0W9	FA83B_HUMAN	FAM83B	1	1.3	0.45	4.0e-5	491.9545	3	12	SSLVFKPTLPEQK	SSLVFKPTLPEQK		13	V20130429-06_FTMSms2hcd	31.685	542	554	13.5	4.0e-5	1.5e-7	1	114800.1	HUMAN	Protein FAM83B
[132]		O94772	LY6H_HUMAN	LY6H	1	9.3	0.42	1.4e-4	728.7965	2	18	QCQPSDTVCASVR	Q(Gln->pyro-Glu)CQPSDTVCAS(Phospho)VR	Gln->pyro-Glu@44;Phospho@54=9	13	V20130429-06_FTMSms2hcd	10.697	44	56	16.2	1.4e-4	2.9e-7	1	14669.2	HUMAN	Lymphocyte antigen 6H
[133]		P06454	PTMA_HUMAN	PTMA	1	11.7	0.40	1.7e-4	719.2753	2	-4.6	AAEDDEDDDVDTK	AAEDDEDDDVDTK		13	V20130429-06_FTMSms2hcd	9.129	91	103	16.4	1.7e-4	5.0e-7	1	12203.0	HUMAN	Prothymosin alpha
[134]		P02768	ALBU_HUMAN	ALB	1	1.1	0.39	0.0021	464.2499	2	-0.99	YLYEIAR	YLYEIAR		7	V20130429-06_FTMSms2hcd	31.123	162	168	22.2	0.0021	5.1e-6	1	69367.4	HUMAN	Serum albumin
[135]		Q14847	LASP1_HUMAN	LASP1	1	5.7	0.37	7.7e-5	784.3677	2	-1.7	TGDTGMLPANYVEAI	TGDTGM(Oxidation)LPANYVEAI	Oxidation@252	15	V20130429-06_FTMSms2hcd	48.591	247	261	14.3	7.7e-5	9.5e-8	1	29717.4	HUMAN	LIM and SH3 domain protein 1
[136]		Q7RTY7	OVCH1_HUMAN	OVCH1	1	1.1	0.37	1.1e-4	727.3231	2	-6.8	LPPQNNPVSTVK	LPPQNNPVS(Phospho)T(Phospho)VK	Phospho@551;Phospho@552	12	V20130429-06_FTMSms2hcd	16.049	543	554	15.2	1.1e-4	1.7e-7	1	125067.2	HUMAN	Ovochymase-1
[137]		Q8N3X6	LCORL_HUMAN	LCORL	1	1.8	0.37	1.1e-4	727.3231	2	9.4	IPQLRVSSVSK	IPQLRVS(Phospho)S(Phospho)VS(Phospho)K	Phospho@420;Phospho@421;Phospho@423	11	V20130429-06_FTMSms2hcd	16.049	414	424	15.2	1.1e-4	1.7e-7	1	66964.2	HUMAN	Ligand-dependent nuclear receptor corepressor-like protein
[138]		P31689	DNJA1_HUMAN	DNAJA1	1	3.8	0.36	1.4e-4	467.9441	4	-2.0	HYNGEAYEDDEHHPR	HYNGEAYEDDEHHPR		15	V20130429-06_FTMSms2hcd	10.399	375	389	15.6	1.4e-4	2.3e-7	1	44868.6	HUMAN	DnaJ homolog subfamily A member 1
[139]		Q9NYF8	BCLF1_HUMAN	BCLAF1	1	2.0	0.34	2.6e-5	512.7783	4	-0.48	STSESFIQHIVSLVHHVK	STSESFIQHIVSLVHHVK		18	V20130429-06_FTMSms2hcd	58.977	600	617	11.4	2.6e-5	4.8e-8	1	106122.9	HUMAN	Bcl-2-associated transcription factor 1
[140]		Q9NXG0	CNTLN_HUMAN	CNTLN	1	0.7	0.28	0.0049	376.5480	3	1.3	RQVAEANALR	RQVAEANALR		10	V20130429-06_FTMSms2hcd	15.819	776	785	23.1	0.0049	1.5e-5	1	161604.6	HUMAN	Centlein
[141]		Q8TCU4	ALMS1_HUMAN	ALMS1	1	0.3	0.25	2.4e-4	586.3270	2	13	ISTVIGPNDQK	ISTVIGPNDQK		11	V20130429-06_FTMSms2hcd	51.039	2026	2036	15.8	2.4e-4	4.4e-7	1	460968.5	HUMAN	Alstrom syndrome protein 1
[142]		Q9H2D6	TARA_HUMAN	TRIOBP	1	0.3	0.25	0.0036	488.2714	2	-0.18	LSEEIEKK	LSEEIEKK		8	V20130429-06_FTMSms2hcd	28.472	2022	2029	22.1	0.0036	6.4e-6	1	261377.7	HUMAN	TRIO and F-actin-binding protein
[143]		P84074	HPCA_HUMAN	HPCA	1	5.2	0.23	0.037	643.8452	2	-4.2	LRPEMLQDLR	LRPEM(Oxidation)LQDLR	Oxidation@12	10	V20130429-06_FTMSms2hcd	15.376	8	17	27.4	0.037	5.8e-5	1	22427.6	HUMAN	Neuron-specific calcium-binding protein hippocalcin
[144]		Q8TB72	PUM2_HUMAN	PUM2	1	0.6	0.20	0.016	358.7190	2	0.85	IVSEIR	IVSEIR		6	V20130429-06_FTMSms2hcd	18.211	941	946	25.1	0.016	3.0e-5	2	114216.7	HUMAN	Pumilio homolog 2
[144-1]	0	Q96LI9	CX058_HUMAN	CXorf58	1	1.8	0.20	0.016	358.7190	2	0.85	IVSEIR	IVSEIR		6	V20130429-06_FTMSms2hcd	18.211	257	262	25.1	0.016	3.0e-5	2	38899.8	HUMAN	Putative uncharacterized protein CXorf58
[145]		Q9Y4F5	K0284_HUMAN	KIAA0284	1	0.6	0.20	4.3e-4	463.7569	2	1.2	VPPGSLNSR	VPPGSLNSR		9	V20130429-06_FTMSms2hcd	18.924	1396	1404	16.6	4.3e-4	1.4e-6	1	171689.4	HUMAN	Protein KIAA0284
[146]		Q5SXM2	SNPC4_HUMAN	SNAPC4	1	1.2	0.16	9.0e-4	645.9807	3	-8.5	EQQEELMRDLAGSKGTK	EQQEELM(Oxidation)RDLAGSKGTK	Oxidation@119	17	V20130429-06_FTMSms2hcd	24.466	113	129	17.9	9.0e-4	9.4e-7	1	159434.1	HUMAN	snRNA-activating protein complex subunit 4
[147]		Q8IUG5	MY18B_HUMAN	MYO18B	1	0.3	0.15	0.0017	442.7366	2	0.084	QMVLHEK	QMVLHEK		7	V20130429-06_FTMSms2hcd	34.010	1769	1775	19.3	0.0017	4.0e-6	1	285187.1	HUMAN	Unconventional myosin-XVIIIb
[148]		Q496Y0	LONF3_HUMAN	LONRF3	1	1.6	0.14	2.8e-4	735.8717	2	-12	AQLPFLAMRSLK	AQLPFLAM(Oxidation)RS(Phospho)LK	Oxidation@737;Phospho@739	12	V20130429-06_FTMSms2hcd	62.123	730	741	15.0	2.8e-4	3.5e-7	1	84490.4	HUMAN	LON peptidase N-terminal domain and RING finger protein 3
[149]		Q9UM11	FZR_HUMAN	FZR1	1	2.0	0.13	0.0011	622.3111	2	9.9	VQDPQTEDRR	VQDPQTEDRR		10	V20130429-06_FTMSms2hcd	20.060	107	116	18.2	0.0011	1.8e-6	1	55179.8	HUMAN	Fizzy-related protein homolog
[150]		Q9UHC7	MKRN1_HUMAN	MKRN1	1	2.3	0.13	2.5e-4	760.7837	2	-14	VGTSSRYRAQR	VGT(Phospho)SS(Phospho)RY(Phospho)RAQR	Phospho@407=19;Phospho@409=24;Phospho@411=39	11	V20130429-06_FTMSms2hcd	12.491	405	415	14.6	2.5e-4	8.7e-7	1	53350.0	HUMAN	E3 ubiquitin-protein ligase makorin-1
[151]		Q9NXW2	DJB12_HUMAN	DNAJB12	1	2.9	0.12	1.3e-4	740.3220	2	7.0	RKQYDQFGDDK	RKQY(Phospho)DQFGDDK	Phospho@170	11	V20130429-06_FTMSms2hcd	31.793	167	177	13.1	1.3e-4	2.1e-7	1	41819.0	HUMAN	DnaJ homolog subfamily B member 12
[152]		Q9H560	ANR19_HUMAN	ANKRD19P	1	6.1	0.12	5.9e-5	882.4195	2	9.7	AAIKGDAAEVEHCLTR	AAIKGDAAEVEHCLT(Phospho)R	Phospho@55	16	V20130429-06_FTMSms2hcd	44.358	41	56	11.2	5.9e-5	6.5e-8	2	30436.2	HUMAN	Putative ankyrin repeat domain-containing protein 19
[152-1]	0	A2A2Z9	AN18B_HUMAN	ANKRD18B	1	1.6	0.12	5.9e-5	882.4195	2	9.7	AAIKGDAAEVEHCLTR	AAIKGDAAEVEHCLT(Phospho)R	Phospho@55	16	V20130429-06_FTMSms2hcd	44.358	41	56	11.2	5.9e-5	6.5e-8	2	118231.7	HUMAN	Ankyrin repeat domain-containing protein 18B
[153]		Q9Y6I7	WSB1_HUMAN	WSB1	1	2.6	0.12	1.7e-4	646.3249	2	-2.9	MASFPPRVNEK	M(Oxidation)ASFPPRVNEK	Oxidation@1	11	V20130429-06_FTMSms2hcd	54.971	1	11	13.6	1.7e-4	2.3e-7	1	47432.6	HUMAN	WD repeat and SOCS box-containing protein 1
[154]		O95747	OXSR1_HUMAN	OXSR1	1	1.7	0.08	7.9e-4	536.2748	2	-0.55	IVEEPQSNR	IVEEPQSNR		9	V20130429-06_FTMSms2hcd	14.317	489	497	16.9	7.9e-4	1.4e-6	1	58022.7	HUMAN	Serine/threonine-protein kinase OSR1
[155]		P98160	PGBM_HUMAN	HSPG2	1	0.3	0.07	9.1e-4	459.5811	3	19	GHTPTQPGALNQR	GHTPTQPGALNQR		13	V20130429-06_FTMSms2hcd	16.426	648	660	17.1	9.1e-4	1.4e-6	1	468834.3	HUMAN	Basement membrane-specific heparan sulfate proteoglycan core protein
[156]		Q13576	IQGA2_HUMAN	IQGAP2	1	0.7	0.06	0.0039	550.3165	2	14	LDGKGEPKGAK	LDGKGEPKGAK		11	V20130429-06_FTMSms2hcd	19.579	1464	1474	20.4	0.0039	8.9e-6	1	180579.4	HUMAN	Ras GTPase-activating-like protein IQGAP2
[157]		Q96HU1	SGSM3_HUMAN	SGSM3	1	1.3	0.03	0.0029	611.3279	2	0.94	FVEVLDERSK	FVEVLDERSK		10	V20130429-06_FTMSms2hcd	18.516	533	542	19.4	0.0029	5.0e-6	1	85354.6	HUMAN	Small G protein signaling modulator 3
[158]		Q03938	ZNF90_HUMAN	ZNF90	1	1.7	0.03	1.3e-4	611.3210	2	-0.32	LSSILSTHKR	LSSILST(Phospho)HKR	Phospho@329|330	10	V20130429-06_FTMSms2hcd	51.304	324	333	12.1	1.3e-4	1.9e-7	1	69058.3	HUMAN	Zinc finger protein 90
[159]		Q75QN2	INT8_HUMAN	INTS8	1	0.7	0.01	0.0024	412.2553	2	-0.35	LPDIPLR	LPDIPLR		7	V20130429-06_FTMSms2hcd	34.091	650	656	18.8	0.0024	2.3e-5	1	113089.1	HUMAN	Integrator complex subunit 8
[160]		Q8IX12	CCAR1_HUMAN	CCAR1	1	1.1	0.01	1.5e-4	807.4077	2	8.1	LLLPTPTVKQESK	LLLPT(Phospho)PTVKQES(Phospho)K	Phospho@1008&1010|1008&1015|1010&1015	13	V20130429-06_FTMSms2hcd	55.503	1004	1016	12.2	1.5e-4	1.8e-7	1	132822.1	HUMAN	Cell division cycle and apoptosis regulator protein 1
